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ABSTRACT
THE ROLE OF AMP-ACTIVATED PROTEIN KINASE IN MOUSE
OOCYTE MATURATION AND SUBSEQUENT EGG ACTIVATION
Ru Ya, B.S
Marquette University, 2013
Mammalian oogenesis begins during fetal development. Oocytes enter meiosis
and arrest at prophase I before birth. Meiosis resumes after proper hormonal signaling,
the oocyte completes meiosis I, and then ovulates in metaphase II, at which stage it
arrests until fertilization occurs. Egg activation occurs upon sperm fertilization, which
includes various physiological processes including calcium influx, release of cortical
granules, and completion of meiosis II. However, egg activation can also occur without
fertilization, which compromises the later embryonic development. The developmental
period from prophase I to metaphase II is referred as oocyte maturation, and involves
crucial dynamic change of the cytoskeleton network. The underlying mechanisms that
control meiotic regulation still remain elusive. It is well established that a high cAMP
level is required to maintain prophase I arrest, whereas mitogen activated protein kinase
(MAPK) activity is needed for later metaphase II arrest of the oocyte. cAMP declines
during meiotic resumption by the activation of phosphodiesterase (PDE), which converts
cAMP into AMP. Elevated AMP activates AMP-activated protein kinase (AMPK). It was
suggested that activation of AMPK provides an additional stimulus for meiotic
resumption, and consistent with this idea, activation of AMPK mediates meiotic
resumption both in vivo and in vitro. However, the role of AMPK in later process
remained to be determined.
My research is focused on the role of AMPK after meiotic resumption. It is
composed of three parts: (1) the effect of AMPK activation on completion of oocyte
maturation; (2) the regulation of AMPK activity by spindle microtubules; and (3) AMPK
regulation of egg activation. Results indicate that AMPK promotes anaphase onset and
formation of the first polar body (PB). Meanwhile, the activity and localization of AMPK
is dependent on spindle microtubule integrity. In addition, AMPK suppresses premature
activation of oocytes by maintaining MAPK activity.
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BACKGROUND
Folliculogenesis and Follicle Structure
The follicle is the functional small unit of the ovary. Each follicle contains a
single oocyte, which is enclosed by layers of somatic cells named granulosa cells. The
oocyte continually exchange metabolite and communicate with this somatic compartment
via gap junctions, transmembrane channels composed of connexins. Connexins are
named after their molecular weight. Cx37 is specifically found at the interface between
oocyte and surrounding somatic cells, while Cx42 is the major type between granulosa
cells (Veitch et al., 2004).
It is difficult to understand oocyte behavior without knowing the structure of the
surrounding environment. A cross section of ovary reveals all types of follicles that are at
different developmental stages (Figure 1). The more developed the follicle is, the larger it
becomes. The majority of follicles inside the ovary are primordial follicles. They are very
small and contain only one layer of flattened granulosa cells. Most primordial follicles
remain dormant throughout a woman’s reproductive life but small percentage of them
periodically become activated and grow into primary follicles. Although a primary
follicle still has one layer of somatic granulosa cells, the size is almost doubled. This is
mainly due to the change of granulosa shape from flat to cuboidal, the initiation of oocyte
growth, and formation of zona pellucida that covers the oocyte (Oktem and Urman, 2010).
A layer of connective tissue, which is called theca, covers the primary follicle. As the
follicle grows, granulosa cells undergo mitosis and produce up to 6 layers of cells.
Multiple granulosa layers mark the secondary follicle stage. While most secondary

	
  

2

follicles undergo atresia (apoptosis of follicle), a few further develop and become tertiary
follicles. Up to this point (early secondary stage), it is generally thought that early follicle
growth is independent of gonadotropin, follicle-stimulating hormone (FSH), since the
receptor expression level is low in the granulosa cells (Oktay et al., 1997).
At the late secondary follicle stage, an antral cavity is formed and filled with the
fluid that is secreted by granulosa cells. Major components of antral fluid are hormones,
anticoagulants, enzymes and electrolytes. The inner granulosa cells around the oocyte are
differentiated into cumulus cells, and those lining the follicle wall are called mural
granulosa cells. Theca cells are also differentiated into theca interna and theca externa.
Several secondary follicles are recruited during each cycle to further develop into tertiary,
or Graafian follicles. This stage of growth is dependent on FSH. Graafian follicles have
accumulated a large amount of antral fluid and become highly vascular in the theca layer.
Selection of the dominant follicles occurs simultaneously. In the end, only the follicles
that are sensitized to gonadotropin and have modulated steroidogenic activity are selected,
while remaining follicles undergo atresia (Oktem and Urman, 2010). Normally only one
Graafian follicle is selected to ovulate in human as opposed to several in rodents.
Follicles at this stage are called preovulatory follicles ( Jone and Lopez, 2006; Hutt and
Abertini, 2007). After ovulation, the ruptured follicle forms the corpus luteum, which
starts secreting progesterone, but degenerates soon if pregnancy does not occur (Jone and
Lopez, 2006).

	
  

Figure 1 Folliculogenesis
Follicles at different developmental stages.
http://www.repropedia.org/folliculogenesis
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Oogenesis
Unlike spermatogenesis, mammalian oogenesis is a discontinuous process.
Primordial germ cells (PGC) originate in the epiblast by tissue-specific interactions
during gastrulation, a process that requires bone morphogenic protein 4 (BMP4) signaling
(Lawson et al., 1999). After the specification, PGCs migrate into the genital ridge. Germ
cells, now called oogonia, undergo multiple rounds of proliferation before they enter
meiosis and arrest at diplotene prophase I stage (Sasaki and Matsui, 2008).
Oocytes undergo incomplete cytokinesis in the last round of mitosis and remain in
cluster before birth. Primordial follicles form in an event called cyst breakdown shortly
after birth, during which the cytoplasmic bridges that link adjacent oocytes are destroyed
and individual oocytes become enclosed by follicle cells (Tingen et al., 2009; Pepling and
Spradling, 1998). Primary oocytes within the primordial follicles remain meiotically
incompetent and arrested at the diplotene prophase I stage. Upon entering puberty,
selected follicles start to develop, oocytes gradually gain meiotic competence,
presumably due to the accumulation of maturation promoting factor (MPF), whose major
components are cyclin B and cyclin-dependent kinase 1 (CDK1) (Mitra and Schultz,
1996).
After a surge of luteinizing hormone (LH), the oocyte inside each Graafian
follicle resumes meiosis. The enlarged nucleus, which is called the germinal vesicle (GV),
undergoes germinal vesicle breakdown (GVB). With the progression of meiosis, the first
polar body (PB) is released. Normally, oocytes are ovulated at the PB stage (metaphase
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II) and where they remain arrested until fertilization occurs (Figure 2). This process (GVMII) is referred to as oocyte maturation (Downs, 2010).

Figure 2 Overview of Oocyte Maturation
Meiotically incompetent oocyte gradually grows and acquires meiotic competence inside the
follicle. After receiving a preovulatory gonadotropin surge, the oocyte resumes meiosis. The nuclear
envelope (germinal vesicle) breaks down, the first polar body is released, and the oocyte arrests at
metaphase II until fertilization occurs. Occasionally, oocyte undergoes parthenogenetic activation without
sperm fertilization. The period from GV stage to formation of first PB is called oocyte maturation.

Regulation of Meiotic Arrest
We now have a better understanding of the signaling pathway that maintains
prophase I arrest. High cAMP level within the oocyte is critical. Oocytes contain the
constitutively active G-protein coupled receptor, Gpr3, which activates adenylyl cyclase
(Mehlmann, 2005). cAMP activates protein kinase A (PKA) that suppresses MPF by
phosphorylating MPF regulators, Wee1B and Cdc25B. The PKA mediated
phosphorylation of Wee1 is activating, while that of Cdc25B is inhibitory. Active Wee1
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negatively regulates the MPF component, CDK1. Cdc25B is a phosphatase, which
removes inhibitory phosphorylation on CDK1. The phosphatase activity of Cdc25b is
controlled by PKA: once phosphorylated by PKA, Cdc25B becomes inactive; meanwhile
the phosphorylation of Wee1B by PKA keeps it in active form and blocks the MPF
activity (Oh et al., 2010; Han et al., 2005). Thus, both phosphorylation events inhibit
MPF activity (Figure 3), and ultimately, germinal vesicle breakdown is suppressed.
The somatic compartment within the follicle plays an important role in
maintaining meiotic arrest. Thus, when a meiotically competent oocyte is released from
the follicles, it undergoes spontaneous maturation. In oocytes, the cAMP level is
balanced by its synthesis and degradation, which is controlled by adenylyl cyclase and
oocyte specific phosphodiesterase (PDE), PDE3A, respectively. PDE activity is
negatively regulated by cGMP (Masciarelli et al., 2004) that is produced in granulosa
cells and transferred into the oocyte to maintain the arrest. Indeed, the cGMP level drops
in the oocyte before meiotic resumption (Robinson et al., 2012).It was recently
demonstrated that cGMP is the somatic compartment inhibitor that passes through the
gap junctions and enters the oocyte to suppress PDE activity (Norris et al., 2008, 2009).
In addition to the granulosa cell regulation of oocyte meiotic arrest, the oocyte
itself can also maintain its arrest by modifying gene expression in granulosa cells (Zhang
et al., 2010). Oocyte derived paracrine factors (ODPF) such as BMP15, GDF-9 and Fgf8,
upregulate natriuretic peptide receptor2 (Npr2) guanylate cyclase expression in cumulus
cells. At the same time, the Npr2 receptor’s ligand, NPPC, is spatially separated and
highly expressed in the mural granulosa cells. Activation of Npr2 is thought to be a
critical source of cGMP production in the somatic compartment (Figure 3).
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Figure 3 Regulation of Oocyte Meiotic Arrest
Diagram summarizing the control of meiotic arrest in the absence of LH signal. cGMP is mainly produced
in the somatic compartment by membrane-bound guanylate cyclase, Npr2, which is activated by the ligand,
NPPC. In addition, OOPFs also help increase the Npr2 activity. cGMP diffuses through the gap junction
and transferred into the oocyte where cGMP inhibits PDE activity. Thus, cAMP level remains elevated and
maintains meiotic arrest of oocytes (Conti et al., 2012; Downs, 2010; Zhang et al., 2010; Norris et al.,
2010).
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Regulation of Meiotic Resumption
LH initiates the meiotic resumption of oocytes in vivo. LH receptors are located
on mural granulosa cells and theca cells. According to the current model, there are
several ways for LH to convey the positive signal to the interior part of the follicle. One
way is to activate PKA in granulosa cells that promotes secretion of EGF-like peptides.
EGF-like peptides diffuse to bind receptors that activate the MAPK pathway in granulosa
cells. The activation of MAPK induces closure of gap junctions (Norris et al., 2008),
which decreases the amount of cGMP transferred to the oocyte. At the same time, the
activation of MAPK exerts an unknown positive stimulus to the oocyte. In addition, LH
inhibits Npr2 receptor activity and decreases cGMP production (Robinson et al., 2012).
With less cGMP entering the oocyte, PDE becomes active, and reduces the cAMP level,
leading to meiotic resumption (Figure 4).
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Figure 4 Signals for Meiotic Resumption
Summary of LH, FSH, and EFG-like peptide induced meiotic resumption. LH, FSH promotes
EGF-like peptide production in the granulosa cells, and the activation of EGFR induces gap junction
closure by phosphorylation of Cx43, at the same time, hormonal signaling decreases the guanylate cyclase
activity. With less cGMP being transferred into the oocyte, PDE becomes active and cAMP is broken down
into AMP. This relieves the inhibition of MPF and leads to meiotic resumption. It should be noted that
AMPK is also activated by elevated AMP levels and exert a positive influence on GVB.

Egg Activation
Binding of sperm triggers oocyte activation. The initial event includes an
intracellular calcium spike, followed by subsequent repetitive calcium oscillations,
mainly by activation of the IP3 receptor (Miyazaki et al., 1993). The egg releases cortical
granules, which contain multiple enzymes that modify the zona pellucida and block
polyspermy. The oocyte completes meiosis II, extrudes the second polar body and forms
pronuclei. This entire process is referred to as egg activation.
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Cytostatic factor (CSF) activity develops during metaphase II arrest. CSF is a

multiple component complex, which contains MAPK and an anaphase promoting
complex (APC) inhibitor, early mitotic inhibitor 2 (Emi2). High CSF activity maintains
metaphase II arrest by inhibiting APC and keeping MPF activity high. During egg
activation CSF activity decreases, thus removing the inhibition of APC and driving entry
into anaphase II (Madgwick and Jones, 2007).
Some oocytes undergo spontaneous parthenogenetic activation without sperm
fertilization (Figure 2). There are many contributing factors, such as the tenure of oocyte
inside the oviduct and oocyte quality. Usually, the longer it is in the oviduct, the easier it
gets activated (Kubiak, 1989). Genetic composition is another contributing factor. A
well-known example is the LT/Sv strain of mice, which is genetically predisposed to
parthenogenetic activation (Eppig et al., 1996). LT/Sv mice show a high incidence of
ovarian teratomas, as a result of the oocytes that are directly activated and begin
developing within the follicles. Once GV-stage oocytes are isolated and cultured in vitro,
those oocytes undergo parthenogenetic activation as well, which is manifested by the
formation of interphase pronuclei. In addition, mutations in the genes that are involved in
maintaining MII arrest cause parthenogenetic activation. For instance, oocytes with a
mutation in the MAPK upstream kinase, Mos, fail to arrest at metaphase II and display a
spontaneous activation phenotype (Hashimoto et al., 1994).
Role of AMP-Activated Protein Kinase in Oocyte Maturation

During meiotic resumption, AMP produced from cAMP degradation is a potential
activator for AMPK. AMPK is a heterotrimeric energy sensor protein, which contains a
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catalytic α subunit and regulatory β,γ subunits (Figure 5). There are 2 isoforms for α
subunit (α1,α2), 2 β subunits and 3 γ subunits. AMPK is activated by elevated
AMP/ATP ratio and cellular stress (Salt et al., 1998). Phosphorylation of threonine 172
on the α catalytic subunit is the hallmark of AMPK activation. LKB1 is a tumor
suppresser and shows an important role in establishing cell polarity, which is one of the
upstream kinase of AMPK phosphorylation (Nakada et al., 2010; Williams and Brenman,
2008). In addition, calcium/calmodulin kinase kinase β (CaMKKβ) also activates AMPK
in response to calcium signaling (Hardie et al., 2012). AMPK maintains cellular energy
homeostasis by down-regulating energy consuming pathways (eg, protein synthesis) and
up-regulating the pathways that generate ATP (eg, fatty acid oxidation). Acetyl-CoA
carboxylase (ACC) is one of the AMPK targets and is phosphorylated upon AMPK
activation. When ACC is active, it converts acetyl-coA into malonyl-CoA that inhibits
carnitine palmitoyltransferase-1, an important carrier for transferring fatty-acyl CoA into
mitochondria. Thus, without the transfer of fatty-acyl CoA into mitochondria, βoxidation does not occur. However, when ACC is inhibited by AMPK phosphorylation,
malonyl CoA levels are decreased, carnitine palmitoyltransferase-1 become active and
fatty acid oxidation is promoted. (Downs et al., 2009). In fact, ACC phosphorylation
level is often used as an indicator for AMPK activity. In addition to regulating energy
homeostasis, AMPK is also implicated in many processes including cell growth, polarity
establishment and transcription (Mihaylova and Shaw, 2011).
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Figure 5 The general role of AMPK in the somatic cells
AMPK consists of the catalytic subunit α and two regulatory subunits β and γ. It is activated by the
upstream kinase, LKB1, in the response to elevated AMP to ATP ratio. The activation of AMPK regulates
energy homeostasis, cell growth and the establishment of polarity. In addition, it has a long-term impact on
transcription as well.

Our current model of AMPK involvement in meiotic resumption is depicted in
figure 6. During meiotic arrest, PKA is activated by cAMP, whereas during meiotic
resumption, accumulation of AMP promotes maturation in mouse oocytes by turning on
AMPK (Downs et al., 2002). One of the effects of AMPK on meiotic induction could be
mediated by increasing fatty acid oxidation (Downs et al., 2009; Valsangkar and Downs,
2013).
Our lab has previously demonstrated the role of AMP-activated protein kinase
(AMPK) in mouse oocyte maturation. AMPK is present in the oocyte and the activation
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of AMPK precedes GVB (Chen et al., 2006; Chen and Downs, 2008). The AMPK
activator, aminoimidazole carboxamide ribonucleotide (AICAR), induces GVB and the
inhibitors, compound C and araA, block maturation. Moreover, GVB occurs when
oocytes are challenged by different kinds of stress that are proven to activate AMPK
(LaRosa and Downs, 2006).

Figure 6 The proposed model of AMPK involvement in meiotic induction (adapted from Downs et al.,
2002)
During meiotic arrest, PDE is inactive. Thus, oocytes contain a high level of cAMP that activates
on PKA, which phosphorylates Wee1B and Cdc25B that prevents activation of MPF (see Figure 3).
However, during meiotic induction, PDE becomes active and breaks down cAMP into AMP. The elevated
AMP level activates AMPK, which acts as a positive stimulus to GVB.

	
  

14

Methodology - In Vitro Culture Systems
We use in vitro culture systems to study oocyte maturation. There are three
different types of in vitro culture systems: (i) preovulatory follicle culture, (ii) cumulusenclosed oocyte (CEO) culture and (iii) denuded oocyte (DO) culture (Downs, 2010).
Follicle culture is close to the physiological condition since the oocyte is in an
intact functional unit. The oocyte is maintained in meiotic arrest within the follicle during
the culture in control medium (ie, devoid of inhibitors or stimulants), because the follicle
provides an inhibitory environment. The preovulatory follicle is responsive to luteinizing
hormone (LH), follicle stimulating hormone (FSH) and epidermal growth-factor like
peptides (EGF) (Downs and Chen, 2008; Norris et al., 2010), and the treatment with these
hormones induces intrafollicular oocyte maturation.
CEOs are obtained by physically rupturing preovulatory follicles. However, once
released from the follicle environment, meiotic arrest cannot be maintained and oocytes
undergo spontaneous maturation when cultured in control medium. The inhibitory
follicle environment can be mimicked in vitro by supplementing the medium with
compounds that either increase the cAMP level or inhibit PDE activity within the oocyte.
Commonly used compounds are the cAMP analogue, dibutyryl cAMP (dbcAMP), or the
PDE inhibitors, 3-isobutyl-1-methylxanthine (IBMX) and milrinone. In vitro-arrested
CEOs are responsive to FSH and EGF-like peptides but not LH, because LH receptors
are localized at the mural granulosa cells, which are now uncoupled from CEOs.
DOs are obtained by removing surrounding cumulus cells. Like CEOs, they
undergo spontaneous maturation in the medium, supporting the idea that cGMP produced
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inside the somatic compartment is important for maintaining meiotic arrest. However,
DOs do not respond to FSH, or EGF-like peptides, due to the fact that the receptors are
located on the somatic cells (Figure 7). DO culture is often used to test the direct effect of
a compound on the oocyte without potentially confounding contribution from cumulus or
mural granulosa cells.
Since my work was focused on the event after GVB, spontaneous maturation of
CEO or DO was mostly used for the experiments. The kinetics of GVB is faster in
spontaneous maturation than meiotic induction. Most of the oocytes undergo GVB within
1h as opposed to 4-6h in meiotic induction. A well-aligned metaphase I stage can be
observed at 8h after onset of the culture and extrusion of the PB can be easily observed
starting at 10h after initiation of the culture. It is therefore a convenient culture system for
investigating different aspects of oocyte maturation.
The purpose of my thesis work was to examine the potential role of AMPK in the
events beyond germinal vesicle breakdown. Herein I demonstrate that AMPK is required
at several different times during oogenesis. Firstly, AMPK promotes the completion of
oocyte maturation by accelerating anaphase I onset and first PB formation. Secondly, the
normal functioning of AMPK depends on spindle microtubule integrity. Finally, AMPK
suppresses premature oocyte activation by maintaining MAPK activity.
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Figure 7 In vitro culture system for studying oocyte maturation (adapted from (Downs, 2010)
Oocytes remain at GV stage in the intact follicles when cultured in the control medium, but
resume meiosis in response to LH, FSH and EGFs. Once released from the follicles, CEOs undergo
spontaneous maturation in the medium without meiotic inhibitors. Arrested CEOs respond to FSH, EGFs.
Similarly, DOs mature spontaneously in the control medium without meiotic inhibitors, but they are
unresponsive to hormones when maintained arrest the in meiotic inhibitor.
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CHAPTER I: A ROLE OF AMPK THOUGHOUT MEIOTIC
MATURATION IN THE MOUSE OOCYTE: EVIDENCE FOR
PROMOTION OF POLAR BODY FORMATION AND
SUPPRESSION OF PREMATURE ACTIVATION
Summary
It has been shown that activation of AMPK is involved in the initiation of mouse

oocyte meiotic resumption. The purpose of this study was to examine the role of AMPK
in the entire oocyte maturation period after germinal vesicle breakdown. AMPK
activators greatly promoted the rate and kinetics of polar body formation in both CEOs
and DOs, whereas the AMPK inhibitors, compound C and Ara A, had opposite effects on
polar body formation. Moreover, compound C stimulated the premature activation of
CEOs but not in the DOs. In addition, oocytes isolated from the mice with a shorter
hormonal priming period were predisposed to spontaneous activation, which can be either
significantly increased by compound C or eliminated by the AMPK activator, AICAR
treatment. Immunofluorescent staining showed that active AMPK was associated with
the condensed chromosomes, spindle poles and the midbody during the maturation period.
The α1 subunit of AMPK was colocalized with the chromosomes and the meiotic spindle.
However, there was no specific staining pattern of the α2 subunit. Interestingly, a
temporal disconnect is observed between the requirement of AMPK activity and its effect
on PB formation. AMPK activity is required early during the maturation period for
stimulation of PB. Altogether, these data suggest that AMPK is involved in the entire
oocyte maturation period by promoting the formation of first polar body; meanwhile, it
suppresses premature oocyte activation.
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Introduction

AMPK is a cellular gauge that is activated by an elevated AMP to ATP ratio.
Once activated, it turns on energy production and shuts down energy consuming
processes (Hardie, 2003; Carling, 2004). AMPK consists of one catalytic α subunit and
two regulatory subunits, β and γ. Notably both isoforms of catalytic subunits, α1 and α2,
are expressed in the mouse oocytes (Downs et al., 2002). The role of this energy sensor is
well studied in somatic cells. A small drop in ATP causes relatively big change in AMP
to ATP ratio, which significantly increases AMPK activity (Mihaylova and Shaw, 2011).
The activation of AMPK leads to adaptive changes in growth and differentiation. In
somatic cells, activation of AMPK induces metabolic checkpoint that causes cell cycle
arrest that is mediated by mammalian target of rapamycin (mTOR) (Gwinn et al., 2008).
Interestingly, AMPK seems to have the complete opposite effect on mouse oocyte
meiotic induction. It has been demonstrated in the previous work that activation of
AMPK precedes GVB and mediates hormone-induced maturation, which is demonstrated
by increase in phospho-ACC level after FSH treatment and the appearance of active
AMPK within the germinal vesicle. Blocking AMPK activity with the specific inhibitors,
compound C and Ara A, inhibits meiotic resumption in both CEOs and DOs (Chen et al.,
2006; Downs and Chen, 2006; Chen and Downs, 2008). In addition, meiotic resumption
can also be induced by stress that activate AMPK (LaRosa and Downs, 2006, 2007).
While a role for AMPK in meiotic induction is well documented, its effect on the
later maturation period (after GVB) remains unknown. Herein we demonstrate the

	
  
involvement of AMPK from GVB to metaphase II stage by using pharmacological
activators or inhibitors of AMPK. To test the effect of AMPK modulators on later
maturation events, spontaneous maturation system was mainly used instead of meiotic
induction. Our data suggest that AMPK has a positive stimulation on PB formation and
suppressive effect on premature activation. This involvement of AMPK is further
suggested by the association of active AMPK with chromosomes, spindle poles, and
midbody throughout maturation.
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Materials and Methods

Oocyte Isolation and Culture Conditions
Immature, 19-23-day-old (C57B/6J X SJL/J) F1 mice were used for all
experiments. In most experiments, mice were primed with 5 IU equine chorionic
gonadotropin (eCG) and 2 days later were killed; the ovaries were removed and placed in
culture medium where cumulus cell-enclosed oocytes were released from the
preovulatory follicles when poked with sterile needles. Some experiments utilized
unprimed mice or mice primed only 1 d. Denuded oocytes were obtained by passage of
CEO through mouth-operated small-bore pipets. Oocytes were washed free of other
follicular tissue and transferred to plastic tubes containing 1 ml of the appropriate test
medium. The culture medium used was Eagle’s minimum essential medium with Earle’s
salts (GIBCO/Invitrogen; Carlsbad, CA) supplemented with 0.23 mM pyruvate, penicillin,
streptomycin sulfate and 3 mg/ml crystallized lyophilized bovine serum albumin (ICN
ImmunoBiologicals, Lisle, IL) and buffered with 26 mM bicarbonate.
Immunofluorescent Staining
Staining was performed on oocytes having undergone maturation either in vitro or
in vivo. For the latter, 2-day-primed mice were administered 5 IU hCG and oocytes were
retrieved from antral follicles at varying times post-hCG. Oocytes were fixed with 4%
formaldehyde at 4°C and permeabilized with 0.1% triton in blocking buffer (0.05%
saponin in PBS, pH 7.4, plus 10% sheep serum) for 30 min. Oocytes were then washed
free of triton and continuously blocked for another 90 min at room temperature. Oocytes
were incubated with rabbit primary antibodies (1:100) overnight at 4 °C, washed in
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blocking buffer at room temperature, and incubated with FITC-conjugated sheep antirabbit antibody (1:1,000) at room temperature for 1 hr. For experiments involving alpha
subunit blocking peptide, primary antibodies were incubated for 1 hr at room temperature
with blocking peptide before adding oocytes for overnight incubation. After washing,
oocytes were mounted on prewashed slides with vectashield mounting medium
containing DAPI (Vector Laboratories, Inc., Burlingame, CA), and cover slips were
sealed with nail polish.
Confocal Microscopy
Oocytes were viewed on a laser scanning confocal microscope (Carl Zeiss Co.,
Thornwood, NY) with a 63× objective. During imaging all settings were kept constant, -that is, laser power, detector gain, amplifier offset, amplifier gain, and pinhole size.
Digitally recorded images were exported by LSM Examiner (Carl Zeiss Co.).
Chemicals
Saponin, dbcAMP, 8-Br-adenosine, adenine-9-b-D-arabinofuranoside (araA),
sheep serum, and FITC-labeled sheep anti-rabbit antibody were purchased from Sigma
Chemical Co. (St. Louis, MO). Compound C and AICAR were supplied by Toronto
Research Chemicals, Inc. (North York, Ontario, Canada). Anti-PT172 antibody was from
Cell Signaling Technology (Beverly, MA), and anti- PT172, anti-α1, and anti-α2
blocking peptides were obtained from Santa Cruz Biotech, Inc. (Santa Cruz, CA). Highly
purified ovine FSH was purchased from the National Hormone and Peptide Program
(NHPP), NIDDK, and Dr. A.F. Parlow.
Statistical Analysis
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Oocyte maturation experiments were repeated at least three times with at least 30

oocytes per group per experiment. Data are reported as mean percentage GVB±SEM.
Following arcsin transformation, maturation frequencies were analyzed statistically by
ANOVA followed by Duncan’s multiple range test. For all statistical analyses, a P-value
<0.05 was considered significant.
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Results

Effects of AMPK Modulators on Polar Body Formation
Activators. To test the effect of AMPK activators on PB formation, a dose
response experiment was carried out (Figure 1.1 A). CEOs were incubated with the
increasing concentrations of different AMPK activators, 5-aminoimidazole-4carboxamide-1-b-D-ribofuranoside (AICAR) or AMP for 16-17h before the formation of
the first polar body was assessed. AICAR significantly increased the percentage of the
PB formation by 26% at the most effective dose (0.2mM) tested in vitro. However, it was
inhibitory on PB formation on the highest dose tested, 1mM. AMP gradually increased
the PB percentage at all doses. The extent of stimulation within the two treatment groups
was the same at the most effective concentrations. This suggests that stimulation of
AMPK by activators promotes the completion of the maturation.
To test if the increase in PB rate was due to a fast PB formation kinetics, CEOs
were cultured in either control or 0.2mM AICAR-containing medium, and the presence
of PB was checked starting at 7h and every 3hours thereafter. The presence of PB was
observed neither in control or AICAR-treated group after 7 h of culture. Sixty percent of
the AICAR-treated oocytes showed PB at 10h, while this number was only 28% in the
control oocytes and remained lower at the later time points (Figure 1.1 B). When CEOs
were cultured in 2mM AMP, a similar acceleration of PB formation was observed (data
not shown).
To determine if these agents can directly act on the oocyte, similar experiments
were carried out with DOs. The presence of the PB was assessed 9h after initiation of the
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culture, due to the faster kinetics in the DOs. As expected, AICAR dose dependently
promoted PB formation in DOs, with the most effective dose of 0.1 mM and a 50%
increase in PB rate. The highest dose of AICAR tested (0.5mM) was toxic to the DOs. In
comparison to CEOs, AMP was ineffective on promoting PB in DOs, which may be
caused by the impaired intake. We then tested another AMPK activator, 8-Br-adenosine
(8-Br-Ado), which has been demonstrated to be effective on CEOs (Downs and Chen,
2006). The result showed a similar dose dependent increase in PB formation in DOs
(Figure 1.1 C). In addition, AICAR treatment also significantly increased the PB
formation kinetics in DOs (Figure 1.1D). This positive effect on DO implies that the
activators are acting directly on oocyte itself.
Meiotic resumption in the mouse oocytes can be induced by different stresses that
activate AMPK (LaRosa and Downs, 2006, 2007). Therefore, we decided to test whether
stress can also bring about the similar effect on PB formation. An initial heat stress
experiment was detrimental to oocyte development so we opted to challenge oocytes by
altering their energy metabolism. Since oocyte maturation is an active process that
constantly requires ATP, we decided to pulse oocytes in the energy deficient medium for
short period of time and then followed by recovery in the regular medium. Oocytes were
treated with 2-D-glucose, whose downstream metabolite, 6-phospho-2-D-Glucose, cannot
be further utilized in glycolysis to generate ATP, which is one of the known methods of
activating AMPK. For the experimental group, we incubated DOs in glucose- and
pyruvate- free medium with 10mM 2-D-glucose for 3 h, and then washed and transferred
the oocytes into the regular medium. For controls, one group of oocytes was similarly
treated with the glucose- and pyruvate- free medium in the absence of 2-D-glucose for
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the initial 3h before transfer to control medium; and another control group was cultured
continuously in the 2-D-glucose containing medium in the absence of glucose and
pyruvate for the entire culture period. As shown in figure 1.1E, only the group that was
pulsed with 2-D-glucose showed an increased percentage of PB formation, whereas
continuous exposure with 2-D-glucose inhibited the meiotic progression.
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Figure 1. 1 Effect of AMPK on PB rate and kinetics
(A) CEOs were cultured in MEM/BSA for 16-17 hours in the presence of either AMP or AICAR.
Both dose-dependently promoted polar body formation. (B) Kinetics of polar body formation in CEOs.
CEOs were either cultured in control or in the medium containing 0.2mM AICAR, and oocytes were
checked every 3 hours to assess the polar body rate. (C) The effect of AMPK stimulators on DOs. At the
lower doses, both AICAR and 8-bromoadenosine increased the rate of polar body. No effect was observed
on AMP. (D) Kinetics of PB rate in DOs. DOs were cultured either in control or 0.1mM AICAR. The
frequency of polar body in AICAR group was higher at every time points tested. (E) Short term pulsing
with 2-D-Glucose significantly promoted PB formation.
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Inhibitors. Next we tested the effect of AMPK inhibitors on PB formation.

Consistent with the activator data, treatment with AMPK inhibitors, compound C (Zhou
et al., 2001) and Ara A (Henin et al., 1996) , dose dependently inhibited PB formation in
both CEOs and DOs, with the effect of Ara A less pronounced in DOs. Interestingly,
treatment with compound C induced a higher percentage of oocyte activation in CEOs
(19%) than DOs (9.5%, data not shown), which was never observed with Ara A treatment
(Figure 1.2 A and B). Activated oocytes displayed a predominant pronucleus and
underwent limited cleavage after further culture.
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Figure 1. 2 Effect of AMPK inhibitors on PB formation
(A) CEOs and (B) DOs were cultured for 17h in increasing concentrations of compound C
(0,1,2.5,5µM) and Ara A(0,1,1.5,2 mM). Compound C induced 19% activation of CEOs at 2.5µM.

Effect of Timing the Exposure to AICAR and Compound C on PB Formation and
Activation

In order to determine the window that is susceptible to AMPK activation on PB
stimulation, the AICAR treatment for CEOs was delayed for 0, 2 or 4h. As shown in
figure 1.3, delaying AICAR treatment decreased the extent of PB stimulation, suggesting
an early requirement for AMPK activation on first PB formation. Consistent with this
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data, when compound C treatment was delayed, the inhibition of PB extrusion was also
reduced. When compound C treatment was delayed by 4h, the rate of PB formation was
not significantly different from the control group. Interestingly, the activation rate
induced by compound C was not affected by the delayed exposure, which may indicate
the sensitive window for stimulatory effect of AMPK on PB formation precedes later
inhibitory effect on oocyte activation.
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Figure 1. 3 Effect of delaying AICAR or compound C exposure on PB and activation
CEOs were treated with 0.2mM AICAR or 2.5 µM compound C 0, 2, or 4h after initiation of
culture. Percentages of PB and activation were assessed after a total of 16-17h of culture.

Effects of Hormone Priming on Polar Body Formation and Oocyte Activation
Normally, mouse follicles grow into preovulatory follicle stages 2 days after
receiving PMSG injection. We have shown that oocytes isolated from the mice that were
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injected with PMSG for 1 day (hereafter designated as 1-day primed mice), show a
significantly higher activation rate than those from 2-day primed mice (Downs, 1990).
Here, we further analyzed the effect of AMPK modulators on PB formation and egg
activation. CEOs from unprimed, 1-day primed or 2-day primed mice were cultured for
21-22 h in control medium or medium containing either 0.2 mM AICAR or 2.5 µM
compound C. The PB rates in 2-day primed and 1-day primed oocytes were comparable,
but this number was reduced in CEOs from unprimed mice, suggesting a deficiency in
meiotic competence. Consistent with the previous findings, the percentages of oocytes
undergoing spontaneous activation increased as the priming periods decreased,
confirming a protective effect of priming on spontaneous activation (Downs, 1990).
AICAR increased PB formation in all three groups and eliminated the spontaneous
activation in unprimed and 1-day primed groups. Compound C treatment induced
spontaneous activation in the oocytes from 2-day primed animals and augmented the
activation rates in 1-day primed and unprimed groups (Figure 1.4 A). Together, these
data support the idea that activation of AMPK promotes completion of the maturation
while blocking premature activation.
A kinetics experiment was carried out to determine the timing of oocyte activation
as it relates to PB formation. CEO from 1-day-primed mice were cultured for varying
periods of time from 15 h to 24 h in the presence or absence of 2.5 µM compound C and
assessed for PB formation and activation. In control oocytes, the percentage of oocytes at
MII peaked at 18 h (55%) and then declined to 35% at 24 h (Figure. 1.4B). A similar
pattern was observed in compound C-treated oocytes, but at reduced rates, with PB
frequency peaking at 26% and decreasing 6 h later to 9%. In control oocytes, activation

	
  
was initiated between 18 and 21 h of culture, at the same time PB number started to
decrease. The percentage of activated oocytes at 24 h (17%) was similar to the 20%
decrease in MII oocytes at this time. Activation in compound C-treated oocytes was
initiated as early as 15 h (5%) and increased rapidly thereafter, to 48% at 24 h. These
data suggest that a significant portion of the activated oocytes derived from MII-stage
oocytes.
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Figure 1. 4 Effect of priming on PB formation and oocyte activation
(A) CEO were derived from unprimed mice or mice primed for 1 or 2 days, cultured 21–22 h in
control medium or medium containing 200 mM AICAR or 2.5 mM compound C (Cmpd C), and assessed
for polar body formation and activation; (B) CEO from 1-day-primed mice were cultured 15–24 h in either
the absence (-) or presence (+) of 2.5 mM Cmpd C and assessed every 3h for polar body formation (PB)
and activation (Act).

Immunostaining of Active AMPK Throughout Meiotic Maturation
In order to determine the cellular localization of active AMPK, oocytes were
isolated at different times post-hCG treatment and stained for antibody against the
phospho-threonine 172 site on the catalytic α subunit. As shown in figure 1.5, active
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AMPK was associated with condensed chromosomes after GVB, relocated to spindle
poles during metaphase I, concentrated in the midbody region during anaphase I and
appeared at the spindle poles again during metaphase II.
When we looked at the distribution of AMPK in in vitro matured oocytes, the
same staining patterns were observed regardless of maturation conditions: (1)
spontaneous maturation of CEO; and meiotic induction in (2) dbcAMP-arrested DO
stimulated with AICAR and (3) dbcAMP-arrested CEO stimulated with FSH (Figure
1.6); these results served to validate our in vitro maturation system.
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Figure 1. 5 Immunolocalization of active AMPK throughout oocyte maturation
Oocytes were isolated at varying stages of meiosis after hCG administration to 2-day-primed mice,
fixed and stained with anti-PT172 antibody for active AMPK (green) and DAPI for chromatin (blue). GVB,
germinal vesicle breakdown; PM, prometaphase; MI, metaphase I; Ana, anaphase; MII, metaphase II.
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Figure 1. 6 Localization of active AMPK in maturing oocytes in vivo
From left to right: oocytes were matured in the following maturation conditions (1) spontaneous
maturation of CEO; (2) FSH-induced maturation of CEOs; (3) AICAR-induced maturation of DOs. Oocyte
were fixed and stained with anti-PT172 antibody for active AMPK (green) and DAPI for chromatin (blue).
GVB, germinal vesicle breakdown; MI, metaphase I; Ana, anaphase; MII, metaphase II.
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Immunostaining of isoforms of the catalytic subunit of AMPK
Since there are two different isoforms of alpha catalytic subunit of AMPK in the
mouse oocytes (Downs et al., 2002), we stained each isoform using specific antibodies.
There was no discrete staining of the α2 subunit (data not shown), whereas α1 subunit
showed specific staining with chromosomes after GVB, associated with the spindle at the
later stages (Figure 1.7). This specific staining was eliminated either by neutralizing
antibody with blocking peptide or omitting the primary antibody. Blocking peptide for α2
subunit did not affect the specific spindle staining for α1. Interestingly, this specific
staining pattern of α1 subunit did not coincide with the active AMPK.
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Figure 1. 7 Immunolocalization of the alpha 1 catalytic subunit of AMPK
Oocytes were fixed at varying stages of meiosis following hCG injection to 2-day-primed mice
and stained with anti- α 1 antibody (green) and DAPI for chromatin (blue). Controls in the bottom row
were of MI-stage oocytes and were either not exposed to primary antibody or anti- α 1 antibody was first
treated with α 1 blocking peptide or α 2 blocking peptide. GVB, germinal vesicle breakdown; MI,
metaphase I; Ana, anaphase; MII, metaphase II.

	
  

38
Discussion
Our data suggest that AMPK is involved in the entire mouse oocyte maturation

process. Activation of AMPK promotes the completion of maturation and suppresses
premature egg activation, while inhibition of its activity by AMPK inhibitors, compound
C and AraA, had opposite effects. Compound C, but not AraA, induced spontaneous
activation in CEOs and augmented the activation rate in oocytes from 1-day and
unprimed mice, while AICAR eliminated the activation. Active AMPK associated with
chromosomes during GVB, spindle poles at metaphase I and II, midbody during anaphase.
The α1 catalytic subunit is localized with chromosomes and the meiotic spindle
throughout the maturation period. Altogether, these data indicate a supportive role of
AMPK in the entire oocyte maturation.
Previous work from our lab demonstrated activation of AMPK precedes meiotic
resumption and mediates hormone induced maturation (Chen and Downs, 2008). In this
study we presented evidence for participation of AMPK in later progression of meiosis to
metaphase II. AMPK activators, AICAR and AMP, dose dependently promoted the
frequency and the kinetics of PB formation in CEOs. In fact, this effect of AMPK
activators on PB formation kinetics is mainly due to the early onset of anaphase I through
inactivating spindle checkpoint activity (see chapter III for details). Although AMP is
ineffective in DOs, another activator, 8-Br-Ado, effectively increased PB formation in
DOs. It is unclear why AMP was ineffective in DOs, but cumulus cells are likely required
for the regular uptake. Moreover, when oocytes were pulsed with 2-D-Glucose, which is
known to activate AMPK by depleting ATP (Hurley et al., 2005; Zhu et al., 2005; Park et
al., 2009; Fujimoto et al., 2009; Pradelli et al., 2010), the PB formation was significantly
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increased. It should be noted that although AMPK can also be activated by heat stress,
which induced meiotic resumption in our previous research (LaRosa and Downs, 2007),
it was not effective in stimulating PB in our current study. This is expected, since it has
been demonstrated that heat stress impairs both nuclear and cytoplasmic maturation of
the oocytes and also impairs later developmental competence (Nabenishi et al., 2012;
Wang et al., 2009)
Additional support of the role of AMPK on PB formation was provided by the
inhibitor data. The rate of PB was suppressed by compound C, but to a lesser extent by
Ara A in DOs, where the uptake may have been hindered by removing the cumulus cells.
Compound C treatment induced premature activation of the CEOs, but not as effectively
in DOs. This is consistent with the previous observation that cumulus cells facilitate
activation (Miao et al., 2005). In an earlier study it has been shown that longer period of
hormone priming decreased the susceptibility of oocytes to undergo spontaneous
activation (Downs, 1990). Therefore, we compared the effects of AMPK modulators on
oocytes from differently primed animals. We increased the in vitro culture period because
in vitro aging reduces the ability of oocytes to maintain MPF activity, making them more
susceptible to spontaneous and induced activation (Fissore et al., 2002). Results showed
that compound C treatment augmented oocyte susceptibility to activation from 1-day and
unprimed mice, whereas AICAR eliminated the oocyte activation and promoted the PB
formation, suggesting a protective role of AMPK on premature oocyte activation.
It has been characterized that while most oocytes undergo parthenogenetic
activation after reaching metaphase II stage, some oocytes activate directly from
metaphase I. The well-known examples are LT/Sv and related strains, which display high
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percentage of spontaneous activation (Kaufman and Howlett, 1986; Eppig et al., 1996;
Hirao and Eppig, 1997). To investigate at what stage oocytes become activated after
compound C treatment, a careful kinetics experiment was conducted on oocytes retrieved
from 1-day primed mice. Oocytes were cultured in both the presence and absence of
compound C and the formation of PB and activation rates were assessed. In the control
group, the presence of PB declined after 18h culture, and the decreased number of PB
was offset by the increased percentage of pronucleus formation. This piece of data
indicated that the activated oocytes were derived from metaphase II stage oocytes in the
control group. However, the same situation did not apply to the compound C-treated
group, where the percentage of activation was almost 3 times greater than the decrease in
PB rate. In fact, later immunofluorescent staining of compound C-treated oocytes with
DAPI and tubulin cauptured a portion of them in an anaphase-like state with condensed
chromosomes within the PB, but with chromosomes inside the oocyte that had already
become decondensed (Unpublished data, not shown). This suggested that the activated
oocytes after compound C treatment originated directly from metaphase I, which is also
consistent with the fact that majority of the oocytes arrest at metaphase I after the
compound C treatment (data not shown).
It is well established that metaphase II arrest in oocytes is maintained by high
MPF and MAPK activity. Recently, it has also been shown that the inorganic metal, Zinc,
regulates activity of the APC inhibitor, Emi2, and is a new member of CSF components
(Bernhardt et al., 2011) . 6-dimethylaminopurine (6-DMAP), a general kinase inhibitor, is
widely used to activate oocytes in vitro, and the site of its action is mainly on interrupting
the MPF activity, which is regulated by MAPK (Fan and Sun, 2004; Szollosi et al., 1993;
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Moses and Masui, 1994). Our data suggest that interrupting AMPK activity in the mouse
oocytes interferes with the second meiotic arrest point and leads to activation. In fact, a
later portion of my thesis work determined that AMPK regulates MAPK activity to
prevent premature activation (Chapter III).
Interestingly, AMPK activity is required very early during maturation (<4h after
initiation of the culture) to promote PB, because there was a progressive loss of
stimulation or inhibition of PB formation when AICAR or compound C treatment was
delayed. However, oocyte activation induced by compound C treatment was refractory to
the delayed compound C exposure, at least to the latest delay tested (4h). This suggests
that targets of AMPK for promoting PB formation and oocyte activation are differ in
stages during cell cycle progression.
In fact, AMPK was revealed as an important kinase that knocking down of
AMPK, impaired Drosophila cell cycle progression (Bettencourt-Dias et al., 2004).
However, the relationship between AMPK activation and cell cycle progression in the
somatic cells is opposite to what we have observed in the mouse oocytes. A study by
Jones et al., (2005) showed that a glucose deficiency in mouse primary embryonic
fibroblasts caused a AMPK mediated metabolic checkpoint. Furthermore, cells
expressing constitutively active AMPK α2 subunits arrested at G1/S stage. The same
observation has been confirmed in variety of cell types (Imamura et al., 2001; Igata et al.,
2005; Motoshima et al., 2006; Baumann et al., 2007; Gwinn et al., 2008; Fogarty and
Hardie, 2009; Ishii et al., 2009; Zang et al., 2009). The AMPK upstream kinase, LKB1,
which phosphorylates threonine 172 site on the catalytic α subunit. LKB1 mutation has
been shown to cause an inherited cancer, Peutz-Jeghers syndrome, in humans, which is
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characterized by high incidence of cancer (Kyriakis, 2003; Hemminki et al., 1998; Jenne
et al., 1998). In addition, LKB1 was also implicated in regulating the polarity of
drosophila embryo and human epithelial cell (Alessi et al., 2006; Lee et al., 2007;
Mirouse et al., 2007). Independently, LKB1 was found directly associated with the
meiotic spindle in the mouse oocytes (Szczepańska and Maleszewski, 2005). It would be
interesting to know whether AMPK also exerts same effects in mouse oocytes.
Consistent with the above observations in the somatic cells, AMPK activation
suppresses GVB in pigs (Mayes et al., 2007), cows (Tosca et al., 2007; BilodeauGoeseels, S Sasseville et al., 2007), and nemertean worms (Stricker et al., 2010), and it is
ineffective in inducing meiotic resumption in the rat oocytes (Downs, 2011). Herein, our
data indicated a stimulatory role of AMPK in mouse oocyte meiotic progression at both
G2/M and the first polar body extrusion. Mouse oocytes are different form the somatic
cells in a way that glucose is not the primary energy substance. Instead, oocytes are
mainly dependent on pyruvate that is supplied by the somatic compartment. Increased
glucose concentration suppressed GVB, while lowering glucose levels promotes meiotic
induction, which may relates to AMPK activation (Downs and Mastropolo, 1994; Downs,
1995). Thus, the major discrepancy between mouse oocytes and these from other species
in response to AMPK stimulation might also be due to the differential response to energy
substrates; at least this is the case in the rat oocytes (Downs, 2011).
The involvement of AMPK in the entire maturation process is further supported
by the active AMPK localization. We have previously showed the positive staining of
active AMPK in the germinal vesicle before oocytes undergo GVB. Here we have shown
that active AMPK is associated with the chromosomes following GVB, on the spindle
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poles during metaphase I and metaphase II, and the midbody during anaphase I. This
localization pattern is identical to that reported in somatic cells (Vazquez-Martin et al.,
2009). Furthermore, active AMPK coincides with numerous other kinases that are
important in meiotic maturation--for instances, MEK1/2 (Sun et al., 2008), phosphoprotein kinase C delta (Ma and Koch, 2008), aurora kinase (Yao et al., 2004; Shuda et al.,
2009) and polo-like kinase (Wianny et al., 1998; Pahlavan et al., 2000; Tong et al., 2002;
Fan et al., 2003). Many kinases regulate of spindle microtubule dynamics during mouse
oocyte maturation. I have examined this potential relationship between AMPK and
microtubules in chapter II.
It was of interest to determine the localization patterns of both α 1 and 2 subunits,
since both are present in the mouse oocyte (Downs et al., 2002). There was no discrete
staining pattern of α2 subunit, whereas, the α1 subunit was associated with chromosomes
initially and with the meiotic spindle thereafter. In contrast, the α2 subunit exhibited
distinct localization in the somatic cells (Salt et al., 1998). It is possible that having a
different pattern is the key to opposite effect on cell cycle progression. These results
suggest that unlike the situation in somatic cells, α1, and not α2, may play a more
important role in regulating the maturation of mouse oocytes.
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Chapter II: PERTURBING MICROTUBLE INTEGRITY BLOCKS
AMP-ACTIVATED PROTEIN KINASE-INDUCED MEIOTIC
RESUMPTION IN CULTURED MOUSE OOCYTES
Summary
The oocyte meiotic spindle is comprised of microtubules (MTs) that bind
chromatin and regulate both metaphase plate formation and karyokinesis during meiotic
maturation; however, little is known about the role of MTs in meiosis reinitiation. This
study was conducted to determine if microtubule (MT) integrity is required for meiotic
induction and how it impacts activation of AMP-activated protein kinase (AMPK), an
important participant in the meiotic induction process. Treatment with microtubuledisrupting agents nocodazole and vinblastine dose-dependently suppressed meiotic
resumption in both arrested cumulus cell-enclosed oocytes (CEOs) stimulated with FSH
and arrested denuded oocytes (DOs) stimulated with the AMPK activator, AICAR. This
coincided with suppression of AMPK activation as determined by western blotting and
germinal vesicle immunostaining. Treatment with the MT stabilizer paclitaxol also
suppressed meiotic induction. Targeting actin filament polymerization had only a
marginal effect on meiotic induction. Immunolocalization experiments revealed that
active AMPK colocalized with gamma tubulin during metaphase I and II, while it
localized at the spindle midzone during anaphase. This discrete localization pattern was
dependent on MT integrity. Treatment with nocodazole led to disruption of proper
spindle pole localization of active AMPK, while paclitaxel induced excessive
polymerization of spindle MT and formation of ectopic asters with accentuated AMPK
colocalization. Although oocytes stimulated by AMPK activator increased the rate of
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GVB, spindle formation and PB extrusion, blocking AMPK activity did not influence
peripheral movement of the spindle. These data suggest that the meiosis-inducing action
and localization of AMPK are regulated by MT spindle integrity during mouse oocyte
maturation.
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Introduction
Mammalian oocyte maturation refers to the developmental period between

germinal vesicle breakdown and formation of the first polar body and involves dynamic
changes within the cytoskeletal network. Initially, the meiotic spindle forms at a position
slightly off-center, where the germinal vesicle (GV) was originally located. After
germinal vesicle breakdown (GVB), microtubules start polymerizing around the
condensing chromosomes, and as the chromosomes congress a bipolar metaphase I
spindle is established, with chromosomes correctly aligned at the metaphase plate.
Meiotic spindle migration occurs after its formation and this process relies on a dynamic
microfilament meshwork (Azoury et al., 2008), actin filament nucleator, Formin-2
(Dumont et al., 2007), and RhoGTPase (Na and Zernicka-Goetz, 2006). The peripheral
spindle migration is a crucial process that assures conservation of ooplasm through
asymmetrical cell division of the polar body.
The meiotic spindle association of AMPK is intriguing, because numerous
proteins showing a similar localization pattern are known to regulate meiotic spindle
assembly and function; AMPK has also been shown to have a role in maintenance of
genome integrity and establishment of cell polarity in Drosophila embryos and other
somatic cells (see Discussion). It is well understood that normal cytoskeleton function is
required for later oocyte maturation processes, since it was directly related to spindle
positioning, chromosome segregation. However, less is known about the role of the
cytoskeleton requirement on meiotic induction. So it was of interest to test how
microtubule and spindle integrity was related to AMPK function in mouse oocytes.
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Specifically, we are interested in answering two questions; 1) how does perturbation of
the microtubule integrity affect AMPK mediated meiotic induction in mouse oocytes? 2)
And what is the relation between AMPK and spindle microtubule integrity? Our data
indicate that disruption of microtubule integrity blocks hormone-induced maturation in
meiotically arrested oocytes while coincidentally blocking AMPK activity. Moreover,
active AMPK colocalization with γ-tubulin at microtubule organization centers (MTOC)
during metaphase I and II is dependent on spindle integrity. However, treatment of
oocytes with AMPK inhibitor did not prevent spindle formation, despite suppressing the
completion of meiotic maturation.
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Materials and Methods

Oocyte Isolation and Culture Condition
All procedures were approved by the Marquette University Institutional Animal
Care and Use Committee. Immature, 19-23-day-old (C57B/ 6J✕ SJL/J) F1 female mice
were used for all experiments. Mice were primed with 5IU pregnant mare serum
gonadotropin (PMSG) 2 days before the experiments. Mice were killed by cervical
dislocation and ovaries were removed and placed in the petri dish containing culture
medium. CEOs were isolated by puncturing the follicles with sterile needles. DOs were
obtained by stripping cumulus cell by using mouth operated small-bore pipette. Both
CEOs and DOs were washed twice and transferred to plastic culture tubes containing 1ml
of the appropriate test medium. The culture medium used was Eagle minimum essential
medium (Sigma, St Louis, MO) supplemented with penicillin, streptomycin sulfate,
0.23mM sodium pyruvate and 3mg/ml bovine serum albumin (MP Biomedicals, Solon,
OH).
Immunofluorescent Staining
Oocytes were fixed with microtubule stabilizing buffer as previously described
(Messinger and Albertini, 1991) at 4°C overnight. Oocytes were permeabilized 30 min
with 0.1% triton-100 in blocking solution, which contained 10% donkey serum and 0.5
mg/ml saponin in PBS, followed by 1h in blocking solution minus triton-100. Oocytes
were incubated with antibody recognizing active AMPK (1:100) overnight at 4°C, and
washed 4 times at room temperature in blocking buffer. Oocytes were coincubated with
FITC-conjugated anti-α-tubulin antibody (1:100) and Cy3-conjugated secondary antibody
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(1:100) 1h at room temperature. After washing, oocytes were placed at slides and
mounted with medium containing DAPI (Vector Laboratories, Burlingame, CA).
Confocal Microscopy
Oocytes were viewed on laser scanning confocal microscope (Carl Zeiss Co.,
Thornwood, NY) with a 63X objective. During scanning, all settings were kept constant:
i.e., laser power, detector gain, amplifier offset, amplifier gain, and pinhole size.
Digitally recorded images were exported by LSM Examiner software (Carl Zeiss Co.).
Western Blot Analysis
Oocytes samples were washed with PBS/PVP, then twice with the protease
inhibitor cocktail (Roche, Indianapolis, IN). Samples were treated with Laemmli’s
Buffer with 20% beta-mercaptoethanol at 95°C for 5 minutes. Electrophoresis was
carried out using NuPAGE 3-8% Tris-Acetate Gels (Invitrogen, Carlsbad, CA), and
proteins were transferred to nitrocellulose. Membranes were blocked with 5% non-fat
milk, followed by incubation with primary antibody pACC (1:250, Cell Signaling) at 4°C
overnight. Blots were rinsed with TBS (pH 7.4) and TBS-Tween-20 (0.05%), and
incubated with HRP-conjugated goat anti-rabbit antibody (1:2000 in 5% non-fat milk,
Pierce) at room temperature for 60 min. After washing, protein signals were detected by
Super Signal West Pico Chemiluminescent Substrate (Pierce). Blots were stripped with
Restore Western Blot Stripping Buffer (Thermo Scientific; Rockford, IL) and reprobed
with anti-ACC1 antibody (1:250; Cell signaling) as a loading control. pACC/ACC1 ratio
was quantified with ImageJ software based on protein band density.
Chemicals
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Saponin, dbcAMP, donkey serum, nocodazole, vinblastine, paclitaxel and FITC-

labeled mouse anti-α tubulin were purchased from Sigma-Aldrich Co. (St. Louis, MO).
Cy3-conjugated donkey anti-rabbit antibody was supplied by Jackson ImmmoResearch
(West Grove, PA). AICAR and compound C were obtained from Toronto Research
Chemicals, Inc. (North York, Ontario, Canada). Anti-phospho AMPK (PT172) antibody
was purchased from Cell Signaling Technology (Beverly, MA). Highly purified ovine
FSH was from the National Hormone and Peptide Program (NHPP) and Dr. A.F. Parlow.
Statistical Analysis
All experiments were repeated at least three times and data presented as mean ±
SEM. Percentages of GVB or nuclear stain underwent arcsin transformation and data
were analyzed statistically by ANOVA followed by Duncan’s multiple range test. A Pvalue <0.05 was considered significant.
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Results

Effect of Cytoskeletal Disrupting Agents on Maturation and AMPK Activity
We have shown that AMPK is involved in hormone-induced maturation and its
activation precedes GVB in mouse oocytes (Chen and Downs, 2008). We therefore
determined how perturbing microtubule integrity would affect AMPK activity and
meiotic induction. dbcAMP-arrested CEOs were treated with 0.1µg/ml FSH to induce
meiotic resumption, exposed to increasing concentrations of nocodazole, and assessed
for GVB after 17-18 h. As shown in Figure 2.1A, FSH increased the percentage of GVB
by 62%, while supplementation with nocodazole significantly blocked this increase in a
dose-dependent manner, by 62% at the highest dose tested. DMSO alone, the nocodazole
vehicle, had no effect on meiotic resumption (data not presented). To test for a direct
effect of nocodazole on the oocyte, dbcAMP-arrested DOs were treated with 250µM
AICAR, an AMPK activator, and scored for GVB. AICAR stimulated an increase in
GVB from 23% to 89%. This stimulation was abolished by nocodazole, which
significantly decreased the percentage of maturation to 8% (Figure 2.1B). This inhibition
was completely reversible, thereby demonstrating that the drug did not act through toxic
means.
FSH-treated CEOs were cultured for 4 h and AICAR-treated DOs were cultured
for 2.5 h before fixation and immunofluorescent staining for active AMPK, using an
antibody against phospho-threonine 172 on the alpha catalytic subunit of AMPK. As
previously shown, FSH and AICAR increased phospho-AMPK staining in the germinal
vesicle prior to GVB. This staining pattern is characterized by homogeneous staining
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throughout the germinal vesicle with absence of label within nucleoli (Chen and Downs,
2008). Since nocodazole blocked AICAR- and FSH-induced GVB, it was important to
determine if this GV staining pattern was present after nocodazole treatment of these
oocytes. As shown in Figure 2.1C, 21% of control CEOs arrested in dbcAMP showed
nuclear staining, with a 20% increase following FSH treatment, and exposure to 10 µg/ml
nocodazole eliminated this increase. A similar pattern was evident in DOs: GV staining
was detected in 26% of control oocytes, with this number increasing to 57% after culture
in AICAR, and nocodazole again prevented the response (20% with active AMPK
accumulation in the GV; Figure. 2.1D). These data support the idea that activity of
AMPK is greatly influenced by microtubule integrity. This was confirmed by western
blot analysis of nocodazole-treated oocytes that showed suppression of AICAR-induced
AMPK activity, using phospho-acetyl CoA carboxylase as a marker for AMPK activity
(Figure 2.1E, F).

	
  

Figure 2. 1 Effects of nocodazole treatment on meiotic resumption and AMPK activation
(A) CEOs were cultured in medium containing 300 µM dbcAMP (dbc) plus FSH in the
presence of increasing concentrations of nocodazole. Germinal vesicle breakdown (GVB) was assessed
17-18h later. (B) DOs were cultured with 300 µM dbcAMP plus 250 µM AICAR and treated with
increasing doses of nocodazole. GVB was assessed after 4h of culture. (C) CEOs were cultured in 300
µM dbcAMP alone (control) or dbcAMP plus FSH with or without 10 µg/ml nocodazole; 4h later
oocytes were fixed and processed for PT172 staining. (D) DOs were cultured for 2.5 h in the same
medium as CEOs but with FSH replaced by 250 µM AICAR; oocytes were then processed for PT172
staining. In both C and D, nocodazole reduced the frequency of the GV stain to control levels. (E)
Western blot analysis of pACC of oocytes that were treated as described in B; ACC1 was used as
loading control. (F) Quantification of pACC and ACC1 from western blot. pACC and ACC1 ratio were
normalized to the control dbcAMP-treated group. Groups with no common letter are significantly
different.
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When CEOs were treated with another microtubule-destabilizing agent,

vinblastine, meiotic induction was again suppressed, with a 31% decrease at the highest
concentration tested (Figure 2.2A). Inhibition was even more robust in AICAR-treated
DOs, with 20µg/ml vinblastine reducing the maturation percentage to control levels
(Figure 2.2B).
To test how stabilizing microtubules affects the meiotic induction, the
microtubule-stabilizing agent, paclitaxel was utilized. CEOs were cultured 17-18h and
treated with FSH plus increasing doses of paclitaxel. Similar to the finding with
microtubule disrupting agents, FSH-induced GVB was blocked in dose-dependent
fashion by paclitaxel (Figure 2.2C), and the agent was even more potent in AICARtreated DOs (Figure 2.2D). When FSH- and paclitaxel-treated oocytes were fixed after 4
h and stained with anti-PT172 antibody, no label was observed in the GV; however,
punctate staining was present throughout the cytoplasm (data not shown). When
paclitaxel was added to AICAR-treated DOs, punctate staining of active AMPK was
observed near or within the GV, but with no homogeneous staining within the GV. The
increased punctate staining of active AMPK after paclitaxel treatment may correspond to
excessive stabilization of microtubule polymers.
To determine whether inhibiting actin filament polymerization plays a role in
meiotic induction, cytochalasin D and latrunculin A were added to either FSH-stimulated
CEO cultures or AICAR- stimulated DO cultures. There was no effect of cytochalasin D
on GVB. Latrunculin A showed a modest reduction (29%) of GVB in FSH-treated CEOs
(Figure. 2.2E), but it was toxic to AICAR-treated DOs.
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We decided to test if activating the AMPK downstream pathway, fatty acid

oxidation, would bypass the inhibitory effect of nocodazole on meiotic induction.
Palmitoyl carnitine, the fatty acid derivative that was shown to induce maturation by
increasing fatty acid oxidation, was added to the CEO culture (Downs et al., 2009).
Consistent with the early findings, nocodazole blocked FSH-induced maturation in CEOs;
however, direct stimulation of fatty acid oxidation by palmitoyl acid significantly
reversed this inhibition (Figure 2.2F). These data indicate that the fatty acid oxidation
pathway is still active during microtubule depolymerization, suggesting nocodazole
treatment does not cause a generalized toxicity in the oocytes.
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Figure 2. 2 Effect of additional microtubule-targeted agents on FSH- and AICAR-induced
maturation in vitro
(A, C) CEOs were cultured 17-18 h in medium containing 300 µM dbcAMP plus FSH or (B, D)
DOs were cultured 4 h in 300 µM dbcAMP plus 250 µM AICAR, in the presence of increasing
concentrations of vinblastine (A, B) or paclitaxel (C, D). (E) CEOs were cultured 17-18 h in 300 µM
dbcAMP plus FSH and increasing concentrations of latrunculin A before GVB assessment. (F)
dbcAMP-arrested CEOs were induced to undergo maturation with FSH, and this stimulation was
suppressed by further treatment with nocodazole. Palmitoyl carnitine (50 µM) was added to the latter
group to trigger GVB via activation of fatty acid oxidation. Groups with no common letter are
significantly different.
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Association of Active AMPK with Microtubules and Effect of Microtubule Perturbants on
Localization

Since studies in other labs have demonstrated that the meiotic spindle-associated
localization of numerous proteins is dependent on MT integrity, the next series of
experiments were conducted to confirm this relationship for AMPK. Oocytes undergoing
in vivo maturation were fixed 8 h after human chorionic gonadotropin (hCG) injection to
obtain metaphase I-stage oocytes and stained with antibodies to active AMPK and γtubulin. As expected, AMPK colocalized with γ-tubulin at the spindle poles during MI
(Figure. 2.3A).
To test if active AMPK localization is dependent on spindle microtubule integrity,
microtubule-targeted agents were tested on CEOs during in vitro culture. Isolated CEOs
were arrested in 300µM dibutyryl cAMP (dbcAMP) and then treated with 0.1 µg/ml FSH
to induce maturation. CEOs were cultured for 17 h before addition of the microtubuledepolymerization agent, nocodazole (0.05 µg/ml), or the microtubule-stabilizing agent,
paclitaxel (20 µM), and oocytes were fixed 1 h later and stained for active AMPK and αtubulin. Nocodazole depolymerized the spindle, and as a result, chromosomes became
scattered and, not surprisingly, normal spindle pole localization of active AMPK was
disrupted (Figure. 2.3B). When oocytes were treated with paclitaxel, microtubules were
excessively polymerized and spindles were larger than normal; formation of a double
meiotic spindle was occasionally observed, with 2 points of active AMPK localization at
each pole. Many small asters also appeared in the cytoplasm with colocalized AMPK
(Figure 2.3B). To test whether reestablishment of a bipolar spindle could bring active
AMPK localization back to its normal localization, in-vitro matured MII-stage CEOs
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were subjected to nocodazole (5 µg/ml) for 10 minutes; the nocodazole was then washed
out and oocytes were allowed to recover for 1 h to allow reformation of a bipolar MII
spindle before fixation and processing for immunoflorescent staining. The MII spindle
completely disappeared after 10 min treatment with nocodazole, and active AMPK was
randomly dispersed as before (data not shown). Upon spindle repolymerization, active
AMPK localization returned to the spindle poles (Figure 2.3B), thereby demonstrating
reversibility of the nocodazole effect and a microtubule-dependent localization of active
AMPK in mouse oocytes.
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Figure 2. 3 Immunofluorescent staining of active AMPK and tubulin
(A) Oocytes were collected 8 h after administration of hCG to PMSG-primed mice to obtain
oocytes at MI. Active AMPK (green) is colocalized at the spindle poles with g-tubulin (red). Chromatin,
blue. INSET: MI spindle from triple-stained oocyte showing a-tubulin, green; active AMPK, red;
chromatin, blue. (B) Effect of microtubule-targeted agents on active AMPK localization. CEOs were
cultured 17 h in the presence of 300 µM dbcAMP plus FSH; then either the microtubule-destabilizing agent,
nocodazole (Ncdz, 0.05 µg/ml), or microtubule-stabilizing agent, paclitaxel (Pac, 20 µM), was added and
oocytes were fixed 1h later and processed for immunostaining for active AMPK (PT172, red) and a-tubulin
(green). Nocodazole treatment disrupted the normal spindle pole localization of active AMPK. When
treated with paclitaxel, microtubules were excessively polymerized, and this was associated with increased
AMPK staining. After CEOs were cultured 17 h in the presence of 300 µM dbcAMP plus FSH, oocytes
were exposed to nocodazole (5 µg/ml) for 10 min. The nocodazole was then washed out and oocytes were
allowed to recover for 1h before fixation and immunostaining. Upon microtubule repolymerization, active
AMPK reestablished its normal spindle pole localization. Red, active AMPK; green, α –tubulin; blue,
chromatin. Scale bar, 50 µm.
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Effect of AMPK Modulators on Cytoskeleton Dynamics
Our data suggest microtubule integrity is critical for localization and activity of
AMPK. We next tested if the reverse regulation was true; that is, if AMPK regulates
spindle dynamics. AMPK stimulators, AICAR, AMP and 8-Br-adenosine accelerate PB
formation of spontaneously maturing CEOs (Downs et al., 2010), and it is possible that
this is mediated by accelerated spindle formation. First, CEOs were matured
spontaneously in MEM/BSA control medium in the presence or absence of 200 µM
AICAR and the kinetics of GVB were determined. After 45 minutes of AICAR
treatment, the percentage of GVB was increased from 35% to 52%; thereafter, maturation
percentages were comparable up to105 min of culture (Figure. 2.4A). To examine the
impact of AICAR on spindle formation, CEOs that were cultured in the presence or
absence of AICAR were fixed at discrete time points and processed for α-tubulin
immunofluorescent staining. Polymerization of microtubules into a barrel-shaped spindle
was the criterion used for assessment. AICAR significantly fastened spindle formation at
the early time point (an increase from 12% to 24% at 3 h), which is roughly 1 hour after
GVB (Figure. 2.4B). This trend toward increased spindle formation in AICAR-treated
oocytes continued for the next 2 h, but differences were not significant.
Spindle migration is important for asymmetric cell division in oocytes, which
helps minimize loss of cytoplasm during polar body extrusion. We determined whether
blocking AMPK activity could influence the migration of the meiotic spindle.
Spontaneously maturing CEOs were supplemented with the AMPK inhibitor, compound
C, and position of the spindle was checked at 8,12 and 16 h after initiation of culture.
Spindles were considered to have migrated to the periphery if they were located more
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than one-half the radius of the oocyte from its center. As shown in Figure 2.4C, by 8h
culture 79% of the control oocytes had a peripherally-located spindle; this number was 68%
in compound C-treated oocytes, which was not significantly different from controls. By
16 h, most CEOs in control medium had released the first polar body and 95% of the
oocyte spindles were peripherally localized. The supplementation of compound C
significantly blocked PB formation, but did not interfere with the peripheral movement of
the spindle.
Finally, we tested whether inhibition of AMPK activity would perturb actin
microfilament dynamics, especially the polymerization status of the cortical region.
Extensive actin polymerization occurs in the cortical area and facilitates attachment of the
outer-most spindle pole to the cortex (Azoury et al., 2008). When CEOs were cultured in
control MEM or medium containing 2.5 µM compound C for 9.5 h and 11.5 h and
processed for phalloidin staining, normal F actin polymerization was observed in both
groups (data not shown). Thus, compound C treatment did not interfere with polar body
formation by blocking actin microfilament polymerization.
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Figure 2. 4 Effect of AMPK modulators on spontaneous maturation, early spindle formation and
spindle periphery movement
(A) Effect of AMPK activator, AICAR, on spontaneous maturation. CEOs were cultured in
control MEM or medium supplemented with 250 µM AICAR, and percentage of GVB was checked at
45, 75 and 105 min after initiation of the culture. (B) Effect of AICAR on early spindle formation.
CEOs were cultured in MEM or MEM plus 250 µM AICAR for 3, 4, and 5 h before spindle formation
was assessed by immunofluorescent staining. (C) Effect of the AMPK inhibitor, compound C, on
spindle periphery movement. CEOs were cultured in control medium or medium containing 2.5 µM
compound C. Spindle periphery movement was examined at the indicated time points. An asterisk
denotes a significant difference from the corresponding control.
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Discussion
In this study, we show that perturbing microtubule integrity in mouse oocytes

reversibly interferes with meiotic induction of CEOs by FSH and DOs by AICAR, which
is accompanied by the loss of AMPK activity. It also disrupts the normal localization of
active AMPK during maturation. On the other hand, microfilament perturbants had little
effect on maturation. While AMPK stimulation accelerated both GVB and spindle
formation, blocking its activity with compound C did not affect actin polymerization or
interfere with peripheral spindle migration, though karyokinesis was suppressed.
Disruption of microtubules with nocodazole and vinblastine, as well as their
stabilization with paclitaxel, blocked both AICAR-induced maturation in DO and FSHinduced maturation in CEO. This was associated with suppression of AMPK activation,
as determined by Western blotting of phospho-ACC as well as loss of pAMPK staining in
the germinal vesicle that occurs prior to meiotic resumption (Chen and Downs, 2008).
Compartmentalization is one of the many ways of controlling signal transduction and cell
cycle (Pines, 1999). Best-known examples in oocyte meiosis are MPF and its two
regulatory components Cdc25B and Wee1. MPF is more concentrated in the cytoplasm
during GV arrest, whereas both Cdc25B phosphatase and MPF adopt nuclear localization
shortly before GVB, where Cdc25B keeps MPF activated; at the same time, Wee1 is
exported from the nucleus to relieve the inhibition on MPF (Oh et al., 2010). MAPK,
which is required for GVB, also translocates to the germinal vesicle just before GVB in
the pig oocytes (Inoue et al., 1998). That nocodazole and paclitaxel suppressed GV
staining of pAMPK in FSH- and AICAR-treated oocytes, coincident with a reduction in
meiotic resumption, suggests a microtubule-dependent step within the oocyte in AMPK
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regulation of meiosis that involves nuclear localization. Nuclear transport is gated by the
pore complexes that span the nuclear membrane (Adams and Wente, 2013; Stewart,
2007). Cytoskeleton is required for successful nuclear imports of some proteins, such as
p53 and parathyroid hormone-related protein (Salman et al., 2005; Rathinasamy and
Panda, 2008; Giannakakou et al., 2000; Lam et al., 2002). It has been proposed that MPF
is translocated to the periphery of the nucleus by microtubule dependent transport before
it is imported into the nucleus, and this is thought to be critical for meiotic resumption
(Van-Blerkom, 1991; Albertini, 1992). Perhaps a similar mechanism applies for AMPK
even though we cannot rule out the possibility that disrupting microtubule dynamics
interferes with the regular special organization of other proteins that help to drive meiotic
resumption in response to FSH and AICAR. Consistent with this idea, nocodazolesuppressed AMPK activity, as assessed by western analysis.
Nocodazole was shown to block GVB in spontaneously maturing rat oocytes
(Albertini, 1987), but we did not observe a similar inhibitory action on spontaneously
maturing mouse oocytes (data not shown), results consistent with those of others
(Wassarman et al., 1976; Van-Blerkom and Bell, 1986). Supplementation with taxol also
did not affect the GVB of spontaneously maturing mouse oocytes (data not shown) and
this has been shown by others for both rat and mouse oocytes; however, like the effects
with nocodazole, taxol impairs later meiotic progression, resulting in failure of
karyokinesis in mouse oocytes (Albertini, 1987; Combelles and Albertini, 2001). These
distinct effects of microtubule perturbants provide another piece of evidence on the
differences between the two species regarding meiotic regulation (cf, Downs, 2011). In
addition, these data suggest that the differences exist between spontaneous maturation
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and meiotic induction of the oocytes, the latter is more sensitive to perturbation of the
microtubule integrity.
In a previous study (Downs et al, 2010), we demonstrated that active AMPK
associates with chromosomes after GVB, localizes to the spindle pole during Metaphase I
and II, and moves to the spindle midzone during anaphase. Here we show that active
AMPK colocalizes with γ-tubulin, indicating an association with spindle organizing
centers during formation of metaphase I spindles. This distribution pattern of pAMPK
during oocyte maturation is similar to that occurring during mitosis of somatic cells
(Vazquez-Martin et al, 2009) and is consistent with a reported role for AMPK in cell
cycle progression (Bettencourt-Dias et al., 2004; Alessi et al., 2006; Koh and Chung,
2007; Williams and Brenman, 2008). The translocation of AMPK throughout maturation
suggests a dynamic process at work. The poleward transport of active AMPK might be
dependent on the minus-end directed motor protein, dynein, which has been shown to be
critical for spindle pole transport of proteins such as NuMA and Eg5 (Merdes et al., 2000;
Uteng et al., 2008).
Since AMPK shows a close association with microtubule containing structures, it
is not surprising that perturbation of microtubules dramatically affected the localization
of AMPK within the oocyte. Nocodazole destruction of spindle structure led to dispersal
of active AMPK in a punctate staining pattern that coincided with staining of microtubule
asters, indicating that the localization pattern of active AMPK is dependent on the
integrity of the meiotic spindle and presence of microtubule organizing centers (MTOCs).
Mouse oocytes have multiple acentriolar MTOCs that can be grouped into two subsets:
one is associated with the meiotic spindle and the other is cortical (Maro et al., 1985;
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Schatten et al., 1986; Messinger and Albertini, 1991). Active AMPK was associated with
both types of MTOCs. Active AMPK is more concentrated around MTOCs that is
associated with spindle, since stabilization of microtubules with paclitaxel treatment
induced further accumulation of AMPK at MTOCs and enlarged spindles.
As discussed in the previous chapter, the upstream kinase of AMPK, LKB1, is
implicated in establishing the cell polarity in numerous types of cells including mouse
oocytes (Zhang et al., 2008; Mirouse et al., 2007; Bonaccorsi et al., 2007; Szczepańska
and Maleszewski, 2005). Thus, it was of interest to test whether AMPK is also involved
in a similar capacity in mouse oocytes. In oocytes, the spindle forms at the center of the
oocyte after GVB, and then migrates toward the oocyte periphery where the PB is
extruded, a process crucial to asymmetric cell division and differentiation of cortex into a
cortical granule-free domain (Sun and Schatten, 2006).
Inhibiting AMPK activity in spontaneously maturing CEO with compound C did
not perturb the peripheral movement of the spindle. Though some recent studies also
suggest the participation of microtubules (Ai et al., 2008), spindle movement in the
oocyte is known to be highly dependent on a dense actin microfilament meshwork
(Azoury et al, 2008). Our results suggest that interfering with AMPK activity does not
affect the integrity of the cortical actin network, because the extensive F actin
polymerization in the cortex near the spindle appeared unperturbed by compound C
treatment. Myosin regulatory light chain (MRLC) is an important component of myosin
II that participates in actomyosin-mediated cytokinesis at the cleavage furrow (Dumont et
al., 2007), and becomes phosphorylated in somatic cells in response to AMPK activation
(Lee et al, 2007). However, it is unclear whether MRLC is a physiological substrate for
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AMPK under energy depleted conditions (Bultot et al., 2009). It will be interesting to
determine if AMPK influences the interaction of actin and myosin at the time of
cytokinesis.
As we discovered in the previous chapter, AMPK activators accelerate the
kinetics of the first polar body formation, which is likely due to the positive effect of
AMPK activation during the early meiotic events. Here we show that both spontaneous
GVB and the meiotic spindle formation rates are increased by AICAR treatment, which
indicate that AMPK manifests an early effect during maturation to shorten the overall
maturation time. This is consistent with the previous finding that AICAR is required
within 4h after the initiation of the culture to promote later polar body formation.
Although we observed a positive effect of AICAR treatment on spindle formation, it is
likely simply due to the accelerated kinetics of GVB.
Numerous proteins exhibit a similar localization pattern and have important roles
in spindle organization and function. For instance, aurora-A kinase induces GVB in
Xenopus oocyte and has to be dephosphorylated for the MI-MII transition (Ma et al.,
2003). In mouse oocytes, aurora-A is critical for spindle assembly, centrosome
maturation and chromosome segregation. Furthermore, its role is not limited to oocyte
maturation, as it also contributes to early embryo spindle organization (Yao et al., 2004;
Ding et al., 2011). Another aurora kinase family member, Aurora-B, is one of the
chromosome passenger proteins and specifically localizes to the metaphase chromosomes,
where it mediates chromosome segregation and spindle kinetochore attachment
(Uzbekova et al., 2008; Shuda et al., 2009). Aurora C kinase localization is similar to
that of active AMPK; moreover, injection of deficient kinase induced failure of
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cytokinesis and disrupted proper localization of kinetochore proteins, BubR1 and Bub
(Yang et al., 2010). Astrin is associated with meiotic spindle microtubules with particular
concentration at the spindle poles, and perturbation of its function greatly compromises
normal spindle integrity and chromosome segregation (Yuan et al., 2009). The apoptosis
inhibitor protein, survivin, mimics AMPK localization in mouse oocytes, and its
depletion adversely affects chromosome alignment and alters normal polar body
extrusion (Sun et al., 2009). Another similarly localized kinase, Polo-like kinase-1 (Plk1),
was implicated in spindle assembly in oocytes and later mitosis in the embryo after
fertilization (Wianny et al., 1998; Tong et al., 2002). In addition to regulating spindle
organization, Plk1 also promotes M phase entry by participating in the MPF
amplification loop (Karaiskou et al., 2004), and blocking its activity with antibody
reduces the GVB rate (Tong et al., 2002). Of particular relevance to the present study is
the recent finding that pharmacological inhibition of Plk1 blocks AMPK activation and
cytokinesis in HeLa cells (Vazquez-Martin et al., 2011). Another kinase, protein kinase
C delta (PKCδ), associates with γ-tubulin and pericentrin, and disruption of its function
leads to spindle disorganization and misalignment of chromosomes (Ma and Koch, 2008).
PKC has also been shown to be involved in the MI-to-MII transition (Viveiros et al.,
2001). Finally, phospho-MEK1/2, the upstream kinase for MAPK activation, displays a
prominent presence at the spindle poles in mouse oocytes, and blocking MAPK leads to
meiotic spindle abnormalities and poor chromatin condensation (Sun et al., 2008). It is
plausible that AMPK interacts with one or more of these proteins to influence meiotic
progression. An alternate scenario is that the kinase docks at MTOCs without
contributing to spindle assembly or function.
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In conclusion, both AMPK localization and activity in the mouse oocyte are

dependent on intact microtubules. Further, while perturbation of microtubule integrity
blocks meiotic induction at the level of the oocyte, it has no effect on spontaneous
maturation. This demonstrates that additional microtubule-sensitive modalities are
required to overcome induction of maturation in meiotically arrested oocytes. Once
isolated from follicles, oocytes undergo spontaneous maturation due to the loss of cGMP
within oocytes. However, it is suggested that an additional unknown stimulus is
generated for meiotic induction. This was supported by the fact that the frequency of the
GVB in CEO after FSH stimulation was greater than the control arrested DO. If the effect
of FSH on GVB is simply mediated by uncoupling of the somatic compartment, one
should expect to see the same level of GVB as DO (Downs et al., 1988). It is possible
that this additional component is sensitive to microtubule perturbants. Altogether, our
data lend further support to the idea that these are distinct processes.
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CHAPTER III: SUPPRESSION OF CHEMICALLY INDUCED AND
SPONTANEOUS MOUSE OOCYTE ACTIVATION BY AMPACTIVATED PROTEIN KINASE

Summary
Oocyte activation is an important process triggered by sperm fertilization that
initiates embryonic development. However, parthenogenetic activation can occur either
spontaneously or with chemical treatments. The LT/Sv mouse strain is genetically
predisposed to spontaneous activation. LT/Sv oocytes have a cell cycle defect and are
ovulated at the metaphase I stage instead of metaphase II. A thorough understanding of
the female meiosis defects in this strain remains elusive. We have shown in chapter I that
AMPK has an important role in stimulating meiotic resumption and promoting
completion of meiosis I while suppressing premature parthenogenetic activation. Here
we show that early activation of AMPK during the oocyte maturation period blocked
chemically induced activation in B6SJL oocytes and spontaneous activation in LT/SvEiJ
oocytes. This inhibitory effect was associated with high levels of MAPK 1/3 activity.
Furthermore, stimulation of AMPK partially rescued the meiotic defects of LT/SvEiJ
mouse oocytes in concert with correction of abnormal spindle pole localization of AMPK
and prolonged spindle assembly checkpoint activity. Altogether, these results confirm a
role for AMPK in sustaining the MII arrest in mature oocytes and suggest that
dysfunctional AMPK contributes to meiotic defects in LT/Sv oocytes.
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Introduction
Mammalian oocytes initiate meiosis during embryonic development and become

arrested at the dictyate stage of prophase I around the time of birth. Following a midcycle gonadotropin stimulus, oocytes within preovulatory follicles resume meiosis,
complete maturation and are ovulated at the metaphase II (MII) stage, where they remain
arrested until fertilization. Germinal vesicle breakdown is driven by M-phase promoting
factor (MPF), a dimer containing catalytic CDK1 and regulatory cyclin B1 subunits;
MPF activity drops during anaphase onset, then rises and stays elevated during MII arrest
(Jones, 2004). Binding of sperm triggers activation of the mature ovum, a series of
events that includes calcium oscillations, completion of meiosis II, release of cortical
granules, and initiation of embryonic development (Horner and Wolfner, 2008; Wakai et
al., 2011). Calcium signaling is a universal component of fertilization in the animal
kingdom (Stricker, 1999); in vertebrates, calcium oscillations are an essential feature of
egg activation and trigger release from MII arrest (Malcuit et al., 2006; Ducibella and
Fissore, 2008). Cytostatic factor (CSF) is important for maintaining metaphase II arrest,
which involves stabilization of MPF by the c-Mos/MAPK1/3 pathway and suppression of
the anaphase promoting complex (APC) by early mitotic inhibitor 2 (Emi2) (Madgwick
and Jones, 2007). Interrupting the c-Mos/MAPK1/3 pathway or mutation of mos leads to
loss of MPF activity and premature egg activation (Colledge et al., 1994; Phillips et al.,
2002; Hashimoto et al., 1994); in addition, knockdown of Emi2 relieves the inhibition of
APC that allows degradation of cyclin B and drives eggs into anaphase (Shoji et al., 2006;
Madgwick et al., 2006), mimicking the effect of sperm-induced calcium oscillations
(Nixon et al., 2002; Suzuki et al., 2010).
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Oocyte aging, chemical treatment, and the intrinsic quality of the oocyte are

factors that can lead to mouse egg activation in the absence of sperm (Kaufman, 1983). It
is well known that freshly ovulated oocytes are resistant to activation but become prone
to activation with increased age and tenure in the oviducts (Marston and Chang, 1964;
Kubiak, 1989; Xu et al., 1997). Chemical treatments such as calcium ionophore
(Nakagawa et al., 2001), phorbol ester (Cuthbertson and Cobbold, 1985; Sun et al., 1999),
protein synthesis inhibitors (Siracusa et al., 1978; Fulka Jr et al., 1994), ethanol
(Kaufman, 1982; Dyban and Khozhai, 1980; Cuthbertson, 1983) and heavy metals
(O’Neill et al., 1991; Ma et al., 2005) are well characterized inducers of parthenogenesis
in oocytes matured both in vivo and in vitro. There are strain-dependent differences in
oocyte susceptibility to spontaneous activation (Cheng et al., 2012), while altering
metabolism or length of hormonal priming can induce parthenogenesis in strains that
normally exhibit very low rates of activation (Downs, 1990; Downs et al., 2010).
The LT/Sv strain is an inbred recombinant mouse line derived from C58 and
BALB strains whose oocytes fail to complete meiosis, leading to arrest at metaphase I
(Kaufman and Howlett, 1986; Maleszewski and Yanagimachi, 1995; Ciemerych and
Kubiak, 1998), due to persistent MPF activity and a poor anaphase I trigger (Hirao and
Eppig, 1997, 1999). This MI arrest is associated with premature activation of oocytes
within the ovary and a high incidence of ovarian teratomas (Stevens and Varnum, 1973;
Eppig et al., 1977; Artzt et al., 1987). The parthenotes advance to the egg cylinder stage
but further development is disrupted, with formation of a disorganized mass of
differentiated cell types (Stevens and Varnum, 1973). A significant number of LT/Sv
oocytes are ovulated at the metaphase I stage, and this arrest appears necessary, but not
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sufficient, to induce parthenogenetic activation (Eppig et al., 1996; Everett et al., 2004).
Apparently the protracted MI arrest brings about changes within the oocyte that
predisposes it to activation. The exact mutation(s) of the LT/Sv mouse remains unknown,
but evidence suggests that the phenotype of LT/Sv oocytes is controlled by multiple
alleles (Artzt et al., 1987; Eppig et al., 1996).
In this series of experiments we further examined the relationship between AMPK
and oocyte activation. We report that AMPK activators suppress both chemically
induced activation in oocytes from C57BL/6J×SJL F1 (B6SJL) mice and spontaneous
activation in oocytes from LT/Sv mice during maturation in vitro, but are less effective in
ovulated B6SJL oocytes. This protection by AMPK was manifest during the oocyte
maturation period and was associated with high levels of MAPK1/3 activity and the
accelerated loss of the spindle assembly checkpoint protein, MAD2. Stimulation of
AMPK in LT/Sv oocytes rescued the “LT phenotype” by reducing the rate of
parthenogenetic activation and promoting anaphase onset and PB formation. These data
support a multifunctional role of AMPK in mouse oocytes and suggest that AMPK
dysfunction may contribute to meiotic defects in LT/Sv oocytes.

	
  

74
Materials and Methods

Chemicals
Unless otherwise noted, chemicals were supplied by Sigma-Aldrich Co. (St. Louis,
MO). AICAR was from Toronto Research Chemicals, Inc. (North York, Ontario, Canada)
and amphiregulin from R&D Systems (Minneapolis, MN). Highly purified ovine FSH
was obtained from the National Hormone and Peptide Program (NHPP) and Dr. A.F.
Parlow. Cy3-conjugated donkey anti-rabbit IgG was purchased from Jackson
ImmmoResearch (West Grove, PA), Anti-phospho AMPK (PT172) antibody from Cell
Signaling Technology (Beverly, MA), and rabbit anti-ERK1/2 and pERK1/2 (MAPK1/3)
antibodies from Sigma Chemical Co. Anti-MAD2 antibody was a kind gift from Dr. E.D.
Salmon (Univ. North Carolina).
Oocyte Isolation and Culture Condition
All procedures were approved by the Marquette University Institutional Animal
Care and Use Committee. Immature, 20-23-day-old C57BL/6J✕ SJL/J F1 (B6SJL) and
LT/SvEiJ female mice were used for all experiments. Mice were primed with 5 IU
pregnant mare serum gonadotropin (PMSG) and oocytes were isolated 2 d later. For
superovulation, 5 IU human gonadotropin (hCG) was administered IP 44-48 h postPSMG and oocytes were isolated at varying times thereafter. Mice were killed by
cervical dislocation and either ovaries or oviducts were removed and placed in a petri
dish containing culture medium. Cumulus cell-enclosed oocytes (CEO) were isolated by
puncturing the follicles with sterile needles. Denuded oocytes (DO) were obtained by
stripping cumulus cells with a mouth operated small-bore pipette. Oviducts were
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punctured with sterile needles to release the expanded cumulus masses, which were then
treated briefly with hyaluronidase to remove cumulus cells.
Both CEOs and DOs were washed twice and transferred to plastic culture tubes
containing 1ml of the appropriate test medium. The culture medium used was Eagle
minimum essential medium (MEM) supplemented with penicillin, streptomycin sulfate,
0.23 mM sodium pyruvate and 3 mg/ml lyophilized crystallized bovine serum albumin
(MP Biomedicals, Solon, OH). Calcium was omitted from the medium when activation
was stimulated with strontium or calcium ionophore A23187.
Chemical Activation
Figure 1 depicts the three activation schemes used in this study. Spontaneous
maturation system was used in this research. CEOs or DOs were cultured 17 h in control
MEM prior to treatment with chemical activators. Cumulus cells were removed from
CEOs at the end of this initial culture period so that only DOs received the activation
stimulus. The three activation regimens are as follows:
1. Strontium. 2.5 h in calcium-free MEM containing 1 mM strontium, wash and
3.5 h culture in control MEM.
2. A23187/puromycin. 5 min in control MEM containing 5 µM calcium
ionophore A23187, wash and 6 h culture in control MEM containing 10µg/ml puromycin.
3. Ethanol. 7 min in control MEM containing 7% EtOH, wash and 6 h culture in
control MEM.
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CEOs or DOs were exposed to AMPK activators (0.2 mM AICAR, 2mM AMP,

or 2 µM RSVA405) during meiotic maturation (pre-maturation) or during/after the
activation procedure (post-maturation). CEOs were hormonally stimulated with 0.1
µg/ml FSH or 50 µg/ml amphiregulin during meiotic maturation. Oocytes were
considered to be activated if they contained a pronucleus, two polar bodies with or
without pronucleus, or had undergone cleavage.
Immunofluorescent Staining
Cumulus cell-free oocytes were fixed with 4% formaldehyde in PBS at 4°C
overnight. They were then permeabilized 30 min with 0.1% triton-100 in blocking
solution, which contained 10% donkey serum and 0.5 mg/ml saponin in PBS, followed
by 1h in blocking solution. Oocytes were incubated with primary antibody (1:100)
overnight at 4°C (either rabbit anti-pPRKAThr172 or rabbit anti-MAD2 antibody), and
washed 4 times at room temperature in blocking buffer. This was followed by 1 h
incubation with FITC-conjugated mouse anti-tubulin antibody (1:100) and Cy3conjugated donkey anti-rabbit IgG antibody (1:100) at room temperature. Some oocytes
were stained for actin using Alexa 568 Fluor phalloidin (Life Technologies, Grand Island,
NY) during the secondary antibody culture period. Oocytes were washed four times,
placed on slides and mounted with medium containing DAPI (Vector Laboratories,
Burlingame, CA).
Confocal Microscopy
Oocytes were observed on a laser scanning confocal microscope (Carl Zeiss Co.,
Thornwood, NY) with a 63X objective. During scanning, all settings were kept constant:
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i.e., laser power, detector gain, amplifier offset, amplifier gain, and pinhole size.
Digitally recorded images were exported by LSM Examiner software (Carl Zeiss Co.).
Western Blot Analysis
Oocyte samples were washed with PBS/PVP, then twice with protease inhibitor
cocktail (Roche, Indianapolis, IN). Samples were lysed by Laemmli’s buffer with 20%
beta-mercaptoethanol at 95°C for 5 minutes. Electrophoresis was carried out using
NuPAGE 4-12% Bis-Tris Gels (InVitrogen, Carlsbad, CA), and proteins were transferred
to nitrocellulose membranes. Membranes were blocked with 5% non-fat milk, followed
by incubation with rabbit anti-pERK1/2 (pMAPK1/3) antibody (1:1000) at 4°C overnight.
Blots were rinsed twice with TBS (pH 7.4) and once with TBS-Tween-20 (0.05%),
followed by incubation with HRP-conjugated goat anti-rabbit IgG antibody (1:5000 in 5%
non-fat milk; Thermo Scientific Pierce, Rockford, IL) at room temperature for 1 h. After
washing, protein signals were detected by super signal west pico chemiluminescent
substrate (Thermo Scientific Pierce). Blots were stripped with restore western blot
stripping buffer (Thermo Scientific Pierce) at room temperature for 15 min and reprobed
with rabbit anti-MAPK1/3 antibody (1:1000). pMAPK1/3:MAPK1/3 ratios were
quantified with ImageJ software based on protein band density.
Statistical Analysis
All experiments were repeated at least three times and data presented as mean ±
SEM. Percentages of activation, polar body, or MAD2 staining underwent arcsin
transformation and data were analyzed statistically by ANOVA followed by Duncan’s

	
  
multiple range test. Students T-test was used to compare paired treatments in some
experiments. A P-value <0.05 was considered significant.
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Results

Effects of AMPK activators on chemically induced activation in B6SJL oocytes
We have previously shown that the AMPK activator, AICAR, prevents premature
activation in spontaneously activating oocytes from B6SJL mice when present during
meiotic maturation (Downs et al., 2010). To test if AMPK stimulation would also block
activation induced by chemical treatments, we adopted three different protocols
depending on the agent(s) used to stimulate activation: strontium, A23187/puromycin or
ethanol. For all three treatments, CEOs or DOs were cultured 17 h in control MEM to
allow for meiotic maturation. Remaining cumulus cells were then removed from CEOs,
and these cumulus cell-free oocytes as well as the mature DOs were exposed to chemical
activating conditions (see Figure 3.1).
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Figure 3. 1 Schematic diagram of activation protocols
For all treatment regimens, CEOs or DOs were first cultured 17 h in control medium to permit
completion of spontaneous maturation. When appropriate, cumulus cells were then removed from CEOs,
and DOs were exposed to chemical activating conditions. (A). Oocytes were treated with strontium in
calcium-free MEM for 2.5 h, washed and then transferred to control MEM for 3.5 h. (B). Oocytes were
exposed to 7% ethanol for 7 min, washed and then transferred to control MEM for 6 h. (C). Oocytes were
treated with A23187 for 5 min, washed and then transferred to puromycin for 6 h.

Strontium-induced activation. The first series of experiments utilized the
activating agent strontium, and cultures were carried out in calcium-free medium, since
the absence of calcium has previously been demonstrated to augment activation by this
agent (Whittingham and Siracusa, 1978). After removing cumulus cells from matured
CEO, oocytes were exposed to 1 mM strontium in calcium-free MEM for 2.5 h, followed
by 3.5 h incubation in the calcium-containing medium. In control oocytes not exposed to
strontium, only 4% were activated compared to 70% activation in strontium-treated
oocytes (Figure. 3.2A). Supplementation of AICAR during the initial maturation period
significantly reduced this number to 15%. Interestingly, later addition of AICAR only
showed a modest reduction of activation (57%, Figure 3.2A). In the next experiment, we
tested the direct effects of AICAR on strontium activation of matured DOs, utilizing the
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same protocol that was used with CEOs. In the absence of cumulus cells, no activation
was observed in oocytes that were only exposed to calcium-free medium, but strontium
treatment only induced 34.8% of DOs to activate. AICAR blocked strontium-induced
activation, and the effect of exposure during meiotic maturation was comparable to that
when exposure followed maturation (Figure. 3.2A).
When the experiment was repeated with native AMP, similar results were
obtained. Exposure to AMP during first culture period significantly reduced the
activation rate in CEOs from 71% to 23% (compared to 4% in controls), whereas
exposure to AMP post-activation did not prevent the activation (Figure. 3.2B). When the
experiment was repeated in DOs, a similar suppression of activation was obtained if
AMP treatment occurred during the maturation period; however, surprisingly, treatment
post-maturation with AMP increased the level of activation (Figure. 3.2B).
We repeated the experiment using a newly described resveratrol analog,
RSVA405(Vingtdeux et al., 2011), which activates AMPK like AICAR, and was proven
to be effective in promoting GVB and PB formation in the mouse oocytes (data not
shown). Consistent with the AICAR and AMP results, RSVA405 suppressed strontiuminduced activation in both CEOs and DOs only when present during the initial maturation
period (Figure 3.2C).
FSH and the EGF-like peptide, amphiregulin (AR), are both potent stimulators of
meiotic maturation of mouse CEOs in vitro, with downstream activation of oocyte
AMPK preceding GVB (Chen and Downs, 2008). We predicted that, because of their
AMPK-stimulating capability, treatment of CEOs with either of these peptides would
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block strontium-induced activation. For this experiment, FSH and AR were present only
during the initial maturation period. These results are shown in Figure. 3.2D. As
expected, FSH and AR significantly reduced the activation rate from 77% to 38% and
33%, respectively.
Since the data suggest that AMPK activation during the maturation period is
important to prevent later strontium-induced activation, an experiment was carried out to
determine the window of requirement for AMPK activation to achieve protective effect
by delaying AICAR treatment by 0,6 or 8 h (Figure 3.2E). There was no loss of
protection when AICAR treatment was delayed by 6 h; however, AICAR started losing
its protective effect when the exposure was delayed by 8 h. This suggests that maximum
protection requires exposure within 6h of the initiation of culture, a time point
corresponding to the early spindle formation.
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Figure 3. 2 Effect of AMPK stimulation and hormones on strontium-induced activation
Treatment with AICAR (A), AMP (B) or RSVA405 (C) during oocyte maturation (pre-maturation)
prevented strontium-induced activation in both CEO and DO, but supplementation after the 17-h
maturation period (post-maturation) was relatively ineffective. (D). Amphiregulin (AR) or FSH suppressed
strontium-induced activation in CEO when present during the initial maturation period. (E). Effect of
delaying AICAR treatment on strontium-induced activation. The inhibitory effect of AICAR on activation
in CEO was decreased when AICAR treatment was initiated 8 h, but not 6 h after the start of culture. All
data are presented as mean percent activated ± SEM. Groups with no common letter are significantly
different (CEO: a-d; DO, w-z).
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Since the cMos-MAPK1/3 pathway is important for maintaining MII arrest

(Colledge et al., 1994; Hashimoto et al., 1994; Phillips et al., 2002), we tested the effect
of AMPK activation in CEO on MAPK1/3 activity following strontium activation.
Oocytes were collected for western blot at 17 h (after maturation), 19.5 h (post-strontium
treatment) and 23 h (after final recovery). As shown in Figure 3.3, control oocytes that
were treated with calcium-free medium alone maintained a high level of MAPK1/3
activity at all three time points. In contrast, oocytes that were treated with strontium
exhibited decreased MAPK1/3 activity after the second and third culture periods.
Consistent with their preventive effect on activation, both AMP- and AICAR-treated
oocytes maintained high MAPK1/3 activity at all time points tested.
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Figure 3. 3 Maintenance of MAPK1/3 activity in oocyte treated with AICAR( AIC) or AMP during
maturation
(A). Representative western blot analysis of p-MAPK1/3 in oocytes treated as described in Figure.
1A. Denuded oocyte extracts were subjected to western blot analysis at the end of each of the three
treatment phases. +/- in the 2nd culture indicates the presence or absence of strontium. Con, control. (B).
Quantitative analysis of pMAPK1/3 signals from western blot, presented as a ratio of the band intensity of
pMAPK1/3 to that of non-phosphorylated MAPK1/3. Mean ± SEM of three blots. Treatments with either
AICAR or AMP maintained high pMAPK1/3 levels that were comparable to the control group. Data are
presented as mean ratio ± SEM.
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A23187/Puromycin-Induced Activation. CEOs were used to test the ability of

AICAR to reverse the activation resulting from sequential treatment of calcium
ionophore A23187 followed by the protein synthesis inhibitor, puromycin. Mature
oocytes were cultured 5 min in 5 µM calcium ionophore A23187 followed by 6 h in
10µg/ml puromycin (Figure. 3.1). In the control group treated with ionophore alone, only
12% of the oocytes underwent activation (Figure. 3.4A). When ionophore-treated
oocytes were subsequently exposed to puromycin, the activation rate was increased to
66%. If oocytes were exposed to AICAR during puromycin exposure, there was no
significant reduction in activation (43%); however, a significant decrease occurred when
AICAR was present during the initial maturation period (31% activation; Figure. 3.4A).
Ethanol-Induced Activation. CEOs were used to test the effect of AICAR on
ethanol-induced activation. When oocytes were exposed for 7 min to 7% ethanol
followed by 6 h culture in control medium (Figure. 1), 78% of the oocytes underwent
activation compared to 1% of controls (Figure. 3.4B). If CEOs were treated with AICAR
during the initial maturation period, ethanol-induced activation was reduced by 54%,
while restricting AICAR treatment to the last 6 h had no effect.
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Figure 3. 4 Treatment with AICAR on A23187/puromycin- and ethanol-induced activation
Treatment with AICAR during, but not following, oocyte maturation blocked A23187/puromycininduced (A) and ethanol-induced (B) activation in CEO. Data are presented as mean percent activated ±
SEM. Groups with no common letter are significantly different.
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Effect of AMPK activation on in vivo aged B6SJL oocytes
It has been well documented that increased aging of ovulated oocytes within the
oviduct increases their susceptibility to spontaneous activation (Marston and Chang,
1964; Kubiak, 1989; Xu et al., 1997). This was confirmed when eggs were retrieved
from the oviducts of superovulated B6SJL mice 16, 20 and 24 h post-hCG and cultured 6
h in control medium. The percentage of activation increased in direct relationship to the
time post-hCG the eggs were retrieved (2, 12 and 32% activation, respectively); there
was a modest trend for suppression of activation at all time points when AICAR was
present during 6 h culture (0, 8 and 22% activation, respectively; Figure. 3.5).
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Figure 3. 5 Effect of AMPK on activation of in vivo matured oocytes
Oocytes were retrieved from oviducts 16, 20 and 24 h post-hCG and cultured 6 h with or without
AICAR. Although there was a trend toward less activation in AICAR-treated oocytes, differences were not
significant. Data are presented as mean percent activated ± SEM.

Effects of AMPK activators on oocyte activation in the LT/SvEiJ strain
Oocytes from the LT/Sv mouse strain exhibit a high rate of spontaneous
activation (Eppig et al., 1977). It was therefore important to determine if AMPK
activators would also suppress this type of oocyte activation. We initially compared
spontaneous activation rates in oocytes from B6SJL and LT/SvEiJ (hereafter designated
LT) mice following 30 h culture in the presence or absence of AICAR. In the absence of
AICAR, activation rates were 2 and 21%, respectively, while AICAR reduced these rates
to 0 and 4% (Figure. 3.6A). When LT CEOs were treated with RSVA405, a similar
reduction in activation was observed (Figure. 3.6B).
To determine the critical window for AMPK activity required to convey this
suppressive effect on LT oocyte activation, oocytes were first cultured in either MEM or
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medium containing AICAR for 17 h, then were transferred to MEM or AICAR
containing medium for another 13 h before activation was assessed. As shown in Figure
3.6C, LT oocytes showed high levels of activation when they were cultured in
control/control and control/AICAR medium. However, the activation rates were
significantly reduced when oocytes were cultured in AICAR/AICAR and AICAR/MEM.
These results are consistent with earlier experiments in B6SJL oocytes showing a
protective effect of AICAR during the initial period of oocyte maturation.
In addition to high rates of spontaneous activation, LT oocytes also fail to
progress past metaphase I both in vivo and during spontaneous maturation in vitro
(Kaufman and Howlett, 1986; Hirao and Eppig, 1997; O’Neill and Kaufman, 1987).
Thus, we tested whether AMPK stimulation could overcome this meiotic defect. CEO
from B6SJL and LT mice were cultured in either control or AICAR-containing medium
for 17 h and assessed for polar body formation. In B6SJL oocytes, 53% formed polar
bodies in control medium, while AICAR increased this number to 78% (Figure.3. 6D).
No polar bodies were observed in LT oocytes cultured in control medium, but 22% of
AICAR-treated oocytes extruded a polar body.
When LT oocytes were stained for active AMPK after 17 h culture in control
medium, we observed a high incidence of abnormal localization. Instead of staining at
both spindle poles, which is the typical staining pattern in B6SJL oocytes, in most LT
oocytes the localization was either shifted away from the poles or was absent at one or
both of the poles (data not presented). Since LT oocytes are arrested at MI for a
prolonged period of time, to eliminate the possibility that this phenotype was due to an
aging effect, we stained oocytes for active AMPK after 8 h in both B6SJL and LT strains,
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when MI has been freshly established, and compared MI localization patterns between
the two strains. Seventy-five percent of B6SJL MI-stage oocytes cultured in control
medium exhibited active AMPK at both spindle poles (Figs 3.6E, 3.7A). However, only
28% of LT MI-stage oocytes had similar bipolar staining (Figs. 3.6E, 3.7B,C). Treatment
with AICAR had no effect in B6SJL oocytes, but doubled the percentage of LT oocytes
with normal AMPK staining (57%).
A comparison of meiotic status in these same oocytes showed that 97% of B6SJL
oocytes cultured 8 h in control medium reached prometaphase or metaphase I, with 3% in
anaphase (Figure. 3.6F). Similarly, 100% of LT oocytes were at metaphase I or
prometaphase. The addition of AICAR accelerated meiotic progression, such that 71%
of B6SJL oocytes were at anaphase or beyond after 8 h of culture. In addition, 33% of
LT oocytes were at anaphase after exposure to AICAR, which, along with the polar body
data above, demonstrates AICAR-induced rescue from metaphase arrest in a significant
percentage of the oocytes.
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Figure 3. 6 Effects of AMPK stimulation on LT/SvEiJ oocytes
(A). AICAR blocked spontaneous activation in LT oocytes during 30 h cultures. (B). RSVA405
had a similar inhibitory action on LT activation. Asterisks in A and B denote a significant difference from
controls (Con). (C). AICAR blocked activation in LT oocytes when present during, but not after, oocyte
maturation. LT/Sv oocytes were first cultured in control MEM (Con) or AICAR for 17 h, and then
transferred to control or AICAR-supplemented medium for another 13 h before activation was assessed. A
different letter denotes a significant difference. (D). AICAR stimulated PB formation in both B6SJL and
LT oocytes during 17 h cultures. An asterisk denotes a significant difference from controls (Con). Data in
A-D are presented as percent activation or PB ± SEM. (E) and (F). pPRKA (PT172) localization (E) and
stage of meiosis (F) in MI stage oocytes after 8 h of culture. AICAR increased the percentage of normal
PT172 spindle pole localization in LT oocytes and increased the percentage of anaphase I (Ana) in oocytes
from both the B6SJL and LT strains. Pro, prometaphase.
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Interestingly, in addition to abnormal active AMPK localization, some AICAR-

treated LT oocytes underwent karyokinesis without cytokinesis after 17h of culture. The
chromosomes were segregated, and MII spindle was established. Actin filament staining
by phalloidin did not detect PB, although the oocytes showed the presence of actin cap,
which is the site close to future PB extrusion and with excessive polymerization of actin
filaments (Figure 3.7D, E). These data suggest that despite the fact that AMPK
stimulation can promote anaphase onset and PB formation, the LT oocytes still manifest
the defect in cell cycle progression.
AICAR Promotes the Loss of Chromosomal MAD2 Staining
It has been previously reported that prolonged spindle assembly checkpoint
(SAC) activity contributes to MI arrest in LT oocytes (Hupalowska et al., 2008). To test
the hypothesis that stimulation of AMPK promotes anaphase onset by overcoming SAC
activity, oocytes were stained for MAD2, one of the major components of SAC (Waters
et al., 1998). We first determined the kinetics of centromeric MAD2 loss in B6SJL CEO
(Figure. 3.7F). Although MAD2 staining intensity was reduced in control oocytes by 6 h,
95% of them still remained positive. Between 6 and 8h the number of MAD2-positive
oocytes decreased by 50%. AICAR treatment accelerated the loss of MAD2, with only
61% and 23% positively staining oocytes at 6 and 8h, respectively. In LT CEO, 98%
stained positive for MAD2 after 8 h of culture, whereas in the AICAR-treated group, it
was reduced to 41% (Figure 3.7G, H, I).
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Figure 3. 7 Immunofluoresecent staining in LT oocytes
(A-C). Immunofluorescent staining of active AMPK in LT oocytes. (A). Normal spindle pole
localization of active AMPK. (B). Shifted spindle pole localization. (C). Missing spindle pole localization.
Green, a-tubulin; Red, pPRKAThr172; Blue, DAPI. (D) and (E). 3D projection of LT oocytes stained with
actin (red) and tubulin (green). Representative staining of oocytes with (D) and without PB (E). (F-I).
AICAR treatment accelerated loss of MAD2 in kinetochores. (F). Kinetics of centromeric MAD2 loss in
B6SJL oocytes in the presence or absence of AICAR. (G). AICAR treatment eliminated prolonged MAD2
kinetochore localization in LT oocytes. The data in (F) and (G) are presented as percent positive MAD2
stain± SEM; the asterisk denotes a significant difference from –AICAR controls. (H) and (I). MAD2 stain
in LT oocytes that were cultured 8 h in control (H) or AICAR-supplemented (I) medium. Red, MAD2;
Blue, DAPI.
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Discussion
In this study, we demonstrate the suppressive effects of AMPK activators on

parthenogenetic activation in mouse oocytes. Stimulation with the AMPK activators
AICAR, AMP or RSVA405 during oocyte maturation prevented both chemically induced
activation in B6SJL mice and spontaneous activation in LT mice, while exposure of
oocytes to these agents after maturation had little effect on either type of activation.
Stimulating AMPK in ovulated, in vivo-matured B6SJL eggs was relatively ineffective in
preventing activation, likely due to the fact that the eggs were already mature at the time
of treatment. Additional effects of AMPK activation on LT oocytes included changes in
active AMPK localization, release from metaphase arrest and a reduction in spindle
checkpoint activity.
Treatment of mouse oocytes with strontium produces repetitive calcium
oscillations that mimic the effect of sperm binding, making it one of the most effective
chemical activating agents (Whittingham and Siracusa, 1978; Bos-Mikich et al., 1995;
Alberio et al., 2001). Nevertheless, exposure to AICAR, AMP or RSVA405 was
sufficient to block strontium-induced activation in both CEO and DO, indicating a direct
action on the oocyte. Twice as many oocytes were activated in CEO compared to DO,
confirming that the presence of cumulus cells during the maturation period promotes
activation (Eppig, 1982; Eppig et al., 2000). The protection by AMP and AICAR was
associated with maintenance of MAPK1/3 phosphorylation, which suggests AMPK may
prevent activation by blocking dephosphorylation of MAPK1/3 and keeping MPF activity
high (Madgwick and Jones, 2007). At this point, we are not sure how this interaction
between AMPK and MAPK happens. Inappropriate activation of the cMos/MAPK1/3
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pathway in Xenopus oocytes can induce a metaphase cell cycle arrest (MacNicol et al.,
1995; Daar et al., 1991), while treating oocytes with inhibitors of MAP2K1 (MEK1), the
immediate upstream MAPK1/3 kinase, alleviates metaphase arrest and stimulates
activation (Hashimoto et al., 1994; Tong et al., 2003). Because treatment with AMPK
activator and strontium were temporally separated, it is possible that this action of AMPK
may reflect an indirect upstream effect, preventing an activation stimulus that acts on the
MAPK1/3 pathway. Strontium-induced oocyte activation involves the interaction of
phospholipase and InsP3 receptor (Zhang et al., 2005) and it is possible that AMPK
activation also interferes with these processes (see also Ross et al., 2008).
Calcium ionophore A23187 only produces a single calcium spike. A23187 and
protein synthesis inhibitors alone each modestly stimulate oocyte activation, but when
oocytes are treated sequentially with these two agents, synergistic activation is observed
(Bos-Mikich et al., 1995; Nakasaka et al., 2000; Nakagawa et al., 2001; Lu et al., 2006).
Brief exposure to ethanol is also an effective trigger for parthenogenetic activation,
likewise acting through simple calcium transients (Alberio et al., 2001; Cuthbertson et al.,
1981; Winston et al., 1995). Nevertheless, both of these treatments produced activation
frequencies comparable to those achieved with strontium. More importantly, AMPK
activators suppressed both A23187/puromycin- and ethanol-induced activation with a
potency resembling that for strontium-treated oocytes. These results are important
because they demonstrate a consistent activation-suppressing response to AMPK
stimulators regardless of the type of chemical activating stimulus.
Hormonal stimulation was protective for oocytes against chemically induced
activation. This protective effect might be mediated by AMPK, since we have previously
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demonstrated that these ligands activate the AMPK pathway within the oocytes (Chen
and Downs, 2008). However, it should be noted that the strontium- induced activation
rate in FSH-treated CEOs was reduced to the level of DO. It is also possible that
hormone-induced uncoupling of the oocytes from cumulus cells decreases the proactivation effect of cumulus cells (Eppig, 1982), thereby rendering it a physiologically
denuded oocyte that is less sensitive to strontium treatment.
AMPK activation during oocyte maturation was essential for optimal protection
from chemically induced activation; later treatment with AMPK activators during either
the activation or recovery periods was largely ineffective. We observed this relationship
consistently for CEOs. However, for DOs, while the exposure of AMPK stimulators
during the maturation period was always inhibitory to activation, the results for recovery
period treatments varied among the groups: RSVA405 had no effect, AICAR was
inhibitory, and, curiously, AMP was stimulatory. This may be due to the fact that the
potency of the activators are different between CEOs and DOs, or in the case of AMP,
there may be an additional effect on the oocyte. This early requirement for AMPK
activation for preventing activation is consistent with our in vivo oocyte maturation data;
AICAR was less effective in preventing spontaneous activation when oocytes were
already matured at the time of the treatment. Further, the AICAR timing experiments
showed that treatment with kinase activator could be delayed up to 6 h after the initiation
of culture and still achieve full protection against activation, a time point that roughly
corresponds to metaphase spindle formation. After 6 h, physiological changes begin to
manifest in the oocyte that make it more susceptible to activating conditions that AMPK
activators cannot overcome. Interestingly, this temporal sensitivity is different than that
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for AMPK promotion of PB formation, which requires earlier exposure to AMPK
activators, around the time of GVB (less than 4h) (Downs et al., 2010). Thus, AMPK not
only induces initiation of meiotic resumption and promotes PB, but also suppresses
oocyte activation, though the data suggest its action is required at different time points
during the maturation period to achieve these effects.
Most LT oocytes have a deficit in cell cycle progression, arresting and ovulating
as metaphase I stage as opposed to metaphase II (Kaufman and Howlett, 1986;
Maleszewski and Yanagimachi, 1995; Ciemerych and Kubiak, 1998), and this metaphase
I arrest is associated with the spontaneous activation phenotype (Eppig et al., 1996),
though the exact link is obscure. Exposure of AMPK activators during the initial
maturation period not only prevented chemically induced maturation in B6SJL, but also
inhibited the spontaneous activation of LT oocytes. Based on the Western blot analysis of
MAPK1/3 activity in B6SJL, it is reasonable to propose that AMPK also acts as the same
way in preventing LT oocyte activation. Hirao and Eppig suggested a role for CSF in the
prolonged metaphase I arrest in LT oocytes based on the fact that high levels of
MAPK1/3 activity is maintained in the LT oocytes (Hirao and Eppig, 1997, 1999;
Maleszewski and Yanagimachi, 1995); however, in wild type oocytes high CSF activity
did not initiate the metaphase I arrest, but only delayed the metaphase-to-anaphase
transition, which suggested that CSF is not the primary cause of metaphase I arrest in this
strain, though it may help maintain it.
If the metaphase I arrest in LT oocytes is, indeed, linked to parthenogenesis, then
it is not surprising that AMPK also stimulated meiotic progression past this arrest point.
Recently, it was reported that prolonged spindle assembly checkpoint (SAC) activity is
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involved in the metaphase I arrest of the LT oocytes (Hupalowska et al., 2008;
Maciejewska et al., 2009). To further address possible downstream mediators of AMPK,
we investigated whether AMPK altered spindle assembly checkpoint dynamics. SAC is a
surveillance mechanism that monitors the integrity of the mitotic spindle and proper
attachment of chromosomes to spindle microtubules and controls activation of the
anaphase-promoting complex (APC) (Chen et al., 1996; Li and Benezra, 1996; Waters et
al., 1999). The same surveillance mechanism also exists in meiotic cells. MAD2 is one of
the components of the SAC complex in mouse and rat oocytes that localizes to
unattached kinetochores, sequestering the main component of APC, Cdc20, thereby
inhibiting APC activity and keeping MPF activity high (Zhang et al., 2004; Wassmann et
al., 2003a). MAD2 is required in mouse oocytes for maintaining MI and preventing
premature anaphase (Wassmann et al., 2003b; Homer et al., 2005; Wang et al., 2009).
Interestingly, as LT oocytes (Hupalowska et al., 2008) or mice (Hoffmann et al., 2012)
age, the MI arrest attenuates, coincident with declining SAC activity. We have shown
herein that AICAR activation stimulated the loss of chromatin MAD2 staining, in concert
with promoting anaphase onset. It is therefore likely that AMPK activator-induced loss
of MAD2 kinetochore binding contributes to both its acceleration of meiosis in B6SJL
oocytes and rescue of LT oocytes from MI arrest and activation. The exact mechanism
on how AMPK regulates MAD2 dynamics remains to be determined.
Ciemerych and Kubiak proposed the major cause for LT phenotype is due to a
lack of an appropriate anaphase I trigger (Ciemerych and Kubiak, 1998). In our study,
activating AMPK provided such a trigger by altering the kinetochore binding dynamics
of MAD2, presumably by affecting SAC activity. Our data suggest that completion of
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maturation driven by AMPK stimulation has a protective role on premature activation.
This is also consistent with the previous compound C data from Chapter I, which blocked
oocyte maturation at metaphase I and induced oocyte activation. In fact, upon close
observation, treating LT oocytes with AICAR reduced activation by 18% (Figure. 3.6A),
which was offset by the number of oocytes that progress to MII (21%; Figure. 3.6D).
Hence, it is tempting to speculate that the LT oocytes that would have activated in the
absence of AICAR are those same oocytes stimulated to reach MII in its presence and
that the nearly complete suppression of activation is due to meiotic escape from MI.
Why the remaining MI-arrested oocytes do not activate is not clear, but it appears that
only about one-fifth of the LT oocytes are prone to activation in our culture conditions.
Also, it would be interesting to know if AMPK stimulation affects the ploidy of the
resulting secondary oocytes, since AICAR treatment accelerated the MAD2 loss from the
kinetochore and the AICAR-treated oocytes enter anaphase earlier than the controls.
Curiously, the percentage of AMPK-treated LT oocytes that entered anaphase
(33%) was higher than the number extruding a PB (21%). This suggested that
karyokinesis occurred in the absence of cytokinesis in a small population of these oocytes.
Indeed, when we stained actin filaments with phalloidin, 4% of AICAR-treated oocytes
after 17 h of culture contained separated homologous chromosomes with a MII spindle,
yet no sign of a PB or contractile ring. The normal polymerization of the actin cap close
to the meiotic spindle suggests that the initial steps of cytokinesis happened successfully
in AICAR-treated LT oocytes, while it is most likely that the downstream formation of
contractile ring was affected. This is supported by the fact that myosin regulatory light
chain (MRLC), an important protein involved in the regulation of contractile ring
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formation, has recently been shown to be a downstream target of AMPK (Lee et al.,
2007; Thaiparambil et al., 2012). If abnormal functioning of AMPK is a major
contributing factor of the LT phenotype, it would be interesting to see if MRLC
localization and function is affected in LT oocytes and how it is related to the partial
rescue of meiosis I arrest by AICAR. It is also possible that a small number of oocytes
had segregated homologous chromosomes that reaggregated after anaphase onset
(Dumont et al., 2007; Pfender et al., 2011). To distinguish these possibilities, a further
observation under time-lapse microscopy is needed.
When LT oocytes were stained for active AMPK after 8 h of culture, abnormal
localization was frequently observed. This was not due to an aging effect following
prolonged MI arrest, because it was observed in oocytes with newly formed meiotic
spindles. Although some control B6SJL oocytes also showed abnormal spindle pole
localization, it was much less frequent. Importantly, supplementation of AICAR
significantly lowered the incidence of AMPK mislocalization in LT oocytes, which
suggests that LT oocytes may have insufficient AMPK function. It has been reported that
metaphase I-arrested LT oocytes have more organized centrosomal material on one
spindle pole than the other (Albertini and Eppig, 1995). This could help explain the
missing or shifted spindle pole localization of active AMPK in these oocytes, since active
AMPK colocalizes with microtubule organizing centers (Chapter II).
Our results support the possibility that defective control of AMPK activity
contributes to the LT phenotype. Genes for the two AMPK catalytic subunits, Prkaa1
and Prkaa2, are located on mouse chromosomes 15 and 4, respectively. However, a
whole genome scan determined that regions in chromosome 1 and 9 were likely
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responsible for LT oocyte defects (Everett et al., 2004). It may be that dysregulation of
AMPK is a downstream consequence of abnormal genetic control in these regions.
Regardless, it is apparent that AMPK has a profound influence on meiotic progression
and regulation of parthenogenetic activation in both B6SJL and LT oocytes. Up to this
point, our experiments have depended largely upon pharmacological manipulation of
AMPK, and genetic ablation experiments are needed for confirmation. Both isoforms of
the catalytic subunit have been knocked out in mice and each is viable and able to
reproduce; however, the double knockout is an embryonic lethal (Viollet et al., 2009). It
will be important to eliminate both isoforms in the oocyte to determine if AMPK is a
requisite player or merely serves to fine tune these physiological processes.
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SUMMARY AND CONCLUSION
The data presented herein suggest an involvement of AMPK in the entire
sequence of events, involving mouse oocyte maturation and subsequent activation. It has
been demonstrated that the activation of AMPK mediates hormone-induced meiotic
resumption in mouse oocytes, and most significantly, the activation precedes GVB. As a
continuation of these study, I investigated the role of AMPK in the completion of
maturation and subsequent oocyte activation process. Surprisingly, AMPK not only had a
role in the meiotic resumption, it also promoted the first polar body formation and
suppressed premature activation. The subsequent study revealed the potential sites of
action for AMPK in meiosis: the positive effect on PB formation is associated with the
accelerated anaphase onset by regulating the dynamics of MAD2 protein localization at
the kinetochores, whereas the inhibitory effect on oocyte activation was linked to the high
levels of MAPK activity, which is critical for maintaining metaphase II arrest.
All evidence suggests a multifunctional role of AMPK in the mouse oocytes
(Figure 4.1). Interestingly, there is a temporal disconnect between the requirement of
AMPK activity and its effects on PB extrusion and oocyte activation. In both cases, the
activity is required early during the maturation period. Consistent with the sequential
events of PB formation and oocyte activation, AMPK activity is required within 4h after
initiation of maturation for optimal promotion of PB and the AICAR treatment can be
delayed up to 6h without losing the maximum protection against oocyte activation. These
data suggest that AMPK is most likely has multiple targets during oocyte maturation.
According to our experimental data, AMPK affects SAC activity to promote anaphase
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onset, and prevents MAPK dephosphorylation to maintain metaphase II arrest, although it
is not clear how these interactions occur. It is safe to speculate that AMPK may induce
GVB by promoting MPF activity; PB formation by regulating MRLC, which is required
for cytokinesis.

Figure 4. 1 The Role of AMPK in Mouse Oocyte Maturation
Figure summarizing the involvement of AMPK during mouse oocyte maturation.
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The localization pattern of active AMPK is consistent with many other kinases

that have been proven to regulate meiotic spindle. Although the reason why active
AMPK adopts this localization pattern throughout maturation still remains elusive. Our
evidence suggests that its localization of active AMPK has functional significance.
Firstly, the germinal vesicle localization of active AMPK seems to be good
indication of oocytes stimulation and impending meiotic resumption. The likely impact of
this accumulation would be increased phosphorylation of its nuclear substrates. The
meiosis-inducing action of AMPK is dependent on the microtubule integrity. Perturbing
microtubule dynamics using microtubule-targeted agents disrupts the normal nuclear
localization of active AMPK, which is consistent with the inhibitory effects of
microtubule perturbants on meiotic induction mediated by AMPK. In somatic cells or
yeast, many conditions induce nuclear localization of AMPKα subunit, such as alkaline
pH (Hong and Carlson, 2007), heat shock (Kodiha et al. 2007), and leptin stimulation
(Suzuki et al., 2007). Even complicating, the upstream kinase, LKB1, was also found to
shuttle between cytoplasm and nucleus (McGee et al., 2003). Compound C blocked both
nuclear localization of active AMPK and GVB, indicating that such localization is vital
for the induction process. However, induction can occur in its absence, since treatment
with palmitoyl carnitine that directly activating downstream fatty acid oxidation pathway
could significantly restore the GVB in nocodazole treated oocytes, though it should be
noted that the extent of GVB after palmitoyl carnitine treatment did not reached the
control level. Thus, we could speculate that activating other targets within the nucleus
may also be involved that is required for stimulating MPF. An inhibitor of nuclear
transport would be a valuable tool in further determining this mechanism.
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The function of the spindle microtubule is well studied for later oocyte maturation

stages. In contrast, less is known about its requirement during meiotic induction. I
demonstrated that microtubule integrity is important for FSH-and AICAR-induced
maturation. Perturbing microtubules blocked meiotic induction but not spontaneous
maturation of oocytes. It is plausible to expect that during GV stage, the microtubule
network is mainly required for protein transport (see p65 for details). One possible
explanation would be that meiotic induction and spontaneous maturation are two
different physiological processes in such that extra microtubule modulator-sensitive
component is required for meiotic induction. Another explanation is mainly contributed
by the different GVB kinetics of meiotic induction and spontaneous maturation of the
mouse oocytes. Once released from the follicles, most mouse oocytes undergo GVB
within an hour as opposed to hours in meiotic induction, which may be too soon for
microtubule modulators to exert an effect.
Secondly, the correct spindle pole localization of active AMPK seems to be
correlated with the oocyte’s potential of completing maturation. Most LT oocytes arrest
at metaphase I and have a high incidence of abnormal active AMPK localization at the
spindle poles. AICAR stimulated meiotic progression of LT oocytes past metaphase I and
significantly restored the normal spindle pole localization of active AMPK. This spindle
pole localization of active AMPK is clearly depending on spindle microtubule integrity.
Although we did not observe a reverse regulation of spindle microtubule by AMPK like
in somatic cells, it is still possible that a residual AMPK activity is present after
compound C treatment, which is sufficient to exert its effects on spindle dynamics.
Recently, it has been found that blocking polo-like kinase 1 activity abolished activation
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of AMPK and the correct spindle apparatus localization. Polo-like kinase 1 is an
important protein that regulates spindle assembly, centrosome maturation, chromosome
congression, separation and cytokinesis(Vazquez-Martin et al., 2011). It is likely that
AMPK is also one of its down stream effectors in the oocytes.
Thirdly, active AMPK also concentrated in the kinetochore region at metaphase I
in addition to the spindle poles, which may indicate its role as a chromosome passenger
protein. Unfortunately, we were unable to perform colocalization staining with
kinetochore because the CENP-A antibody we purchased did not stain. Regardless, this
subcellular pattern is consistent with the data that AICAR accelerated MAD2 loss from
the kinetochore. How this interaction occurs remains to be identified, but research has
shown that AMPK phosphorylates microtubule associated proteins (MAPs) (Mihaylova
and Shaw, 2011), which may relate to this.
Lastly, the midbody localization of the active AMPK during anaphase coincides
with the future cleavage furrow that recruits MRLC. Cytokinesis is a highly coordinated
process that can be divided into multiple stages; specification of the cleavage plane,
ingression of the furrow, formation of the midbody, and abscission. Any defect of the
above processes will lead to cytokinesis failure. Cytokinesis is also dependent on the
actin filaments located outside of the furrow (Normand and King, 2010). Blocking
AMPK with compound C inhibited meiotic progression past metaphase I, but did not
suppress spindle migration and the excessive polymerization of the F actin filaments.
Interestingly, polo-like kinase 1 that is involved in the later stage of cytokinesis also
directs AMPK phosphorylation of MRLC (Vazquez-Martin et al., 2012). We are not sure
whether there is any crosstalk between polo-like kinase and LKB1 regulation of AMPK,
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especially on establishing cell polarity. Based on these observations, I propose that
AMPK is more involved in the later stages of the cytokinesis, such as myosin recruitment
and activation, which are crucial for ingression of the furrow.
The translocation of AMPK throughout maturation suggests a dynamic process at
work, which also coincides with its potential functions at different stages. The germinal
vesicle localization of AMPK is most likely dependent on microtubule meditated nuclear
import. The poleward tanslocation of active AMPK might be dependent on the minus-end
directed motor protein, dynein, which has been shown to be critical for spindle pole
localization of the proteins such as NuMA and Eg5 (Merdes et al., 2000; Uteng et al.,
2008). In contrast, kinesin family members may mediate the midbody translocation of
active AMPK. For instance, citron kinase (CIK-K), a major component of the contractile
ring, requires kinesin family member 14 (KIF-14) for proper localization to the cleavage
site (Gruneberg et al., 2006). It is likely that active AMPK is transported from spindle
poles to the cleavage furrow by plus-end directed kinesin. However, I could not rule out
the possibility that more AMPK is activated and recruited during anaphase. A GFPtagged fusion protein would be useful to track the movement of active AMPK during
maturation.
AMPK restored the meiotic behavior of LT oocytes, which includes release of
metaphase I arrest, suppression of spontaneous activation, and correction of normal
spindle pole localization of the active AMPK. Early development of CSF activity is not
associated with the meiotic defect of LT oocytes. According to these observations, there
are two likely scenarios whereby AMPK may correct the meiotic defects of LT oocytes;
one of these would be that activation of AMPK overrides high levels of CSF activity to
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induce anaphase, yet leaving MAPK1/3 activity intact. The second scenario would be that
activation of AMPK completely restores the normal CSF profile during meiosis in that
premature development of CSF activity is prevented but later helps maintain normal
levels of activity during metaphase II arrest.
Although Western blot analysis of AMPK activity and levels in CEOs were not
different from the control F1 mouse CEOs (data not shown), the direct assaying of
AMPK by western analysis of oocyte phospho-ACC level was hindered by the poor
reproductive performance of LT mice (Westerns of DOs require many more oocytes than
those of CEOs). Regardless, evidence collected so far indicates that the malfunctioning of
AMPK may be an important contributing factor to the LT oocyte phenotypes.
In fact, in addition to LKB1, calcium/camodulin-dependent protein kinase kinase
β (CaMKKβ) is another upstream activator of AMPK. Evidence suggests that CaMKKβ
particularly activates AMPK in neurons and T cells (Mihaylova and Shaw, 2011).
Although there has been report on the involvement of CaMKK on pig oocyte maturation,
they did not distinguish CaMKKα and CaMKKβ (Xu et al., 2009). Furthermore, we are
able to stain oocytes for active LKB1 but not CaMKK (Downs unpublished data). Thus, I
favor the hypothesis that LKB1 pathway is predominantly active in the mouse oocytes.
To why there are opposite consequences for AMPK activation on G2/M transition
between somatic cells and mouse oocytes, below are some possible explanations. 1).
Differential response to energy substrates. High glucose level suppresses GVB (see p43
for details). 2) The origin of the AMP. In oocytes, elevated AMP mostly comes from
degradation of cAMP, while the source is mostly ATP breakdown in somatic cells in
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response to low energy and stress conditions. It is possible that a difference in AMP/ATP
ratios between two types of cells may lead to the differential downstream effects.
It is important to note that our experiments are mainly based on the
pharmacological manipulation of AMPK. An AMPK null mouse model is a valuable tool
for testing the absolute requirement for AMPK in meiotic regulation; however, the
double knockout of both catalytic alpha subunit is embryonic lethal. Thus, we are trying
an alternative route to generate double knockout mice by using the Cre-loxP system in an
α2 mutant mouse background, which should lead to a specific α1 subunit deletion in the
oocytes that are already mutated for α2 allele (Lewandoski et al., 1997). Currently, we
have produced the α1 oocyte-specific knockout animals, and the α1 mutant oocytes did
not exhibit any meiotic defects, which maybe due to the functional redundancy of two
catalytic alpha subunits. However, when the female mice carrying α1 single mutant
oocytes were mated with males that carry two homozygous floxed alleles for α1, the
isolated embryos showed a significantly reduced rate of 2-cell embryo and blastocyst
formation. This is likely caused by the active Cre recombinase in the oocyte that is still
able to excise the floxed α1 allele in the sperm, rendering some of the resulting embryos
null for α1(De-Vries et al., 2000). This result is promising and suggests that α1 subunit is
critical for the early embryonic development. The generation of double knockout mice is
still in progress.
In conclusion, my study has shown a multifunctional role of the energy sensor,
AMPK, in mouse oocyte maturation. It will be important to determine whether similar
functions for AMPK exist in human oocytes.
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